{"better_query": "What are the key advantages of phage display-derived antibodies over traditional antibodies in pathogen detection diagnostics?", "better_answer": {"sections": [{"title": "Introduction/Background", "tldr": "Phage display technology allows antibodies to be developed by selecting genes from bacteriophage libraries, providing significant advantages over traditional antibody production methods. This technology has revolutionized pathogen detection by enabling faster development, better customization, and improved performance characteristics. (LLM Memory)", "text": "\nPhage display technology represents a significant advancement in antibody engineering that has transformed pathogen detection diagnostics. Unlike traditional antibody production methods that rely on animal immunization, phage display involves the expression of foreign peptides or proteins on the surface of bacteriophages (viruses that infect bacteria). This allows for the selection of specific antibody fragments with desired binding properties from large libraries. The technique works by genetically fusing antibody genes to phage coat protein genes, creating a physical link between the antibody's phenotype (binding properties) and its genotype (the encoding DNA). Through multiple rounds of selection called \"biopanning,\" scientists can isolate antibodies with high affinity and specificity for target pathogens. This technology bypasses many limitations of conventional antibody production while offering significant advantages in terms of speed, customization capabilities, and performance characteristics for diagnostic applications. <Model name=\"Anthropic\" version=\"claude-3-7-sonnet-20250219\">", "citations": [], "table": null}, {"title": "Production Advantages", "tldr": "Phage display technology offers significant production advantages over traditional antibody methods, including reduced cost, elimination of animal use, faster development timeframes, and simplified production processes that can be completed in bacterial systems rather than specialized cell cultures. (14 sources)", "text": "\nPhage display technology provides several key production advantages that make it superior to traditional antibody generation methods. Perhaps most significantly, phage display bypasses the need for animal immunization, aligning with EU Directive 2010/63/EU which aims to reduce, refine, and replace animal use in scientific research <Paper corpusId=\"10496834\" paperTitle=\"(McIvor et al., 2013)\" isShortName></Paper> <Paper corpusId=\"9420027\" paperTitle=\"(Smith, 1985)\" isShortName></Paper>. This ethical advantage is complemented by substantial economic benefits, as phage-derived antibodies are considerably less expensive to produce than traditional monoclonal antibodies <Paper corpusId=\"14579386\" paperTitle=\"(Ferrara et al., 2012)\" isShortName></Paper> <Paper corpusId=\"232158116\" paperTitle=\"(Anand et al., 2021)\" isShortName></Paper>.\n\nThe speed of antibody development represents another crucial advantage. While traditional hybridoma approaches typically require months to complete, phage display allows researchers to generate specific antibody fragments in just a few weeks <Paper corpusId=\"221092042\" paperTitle=\"(Chitray et al., 2020)\" isShortName></Paper> <Paper corpusId=\"6845760\" paperTitle=\"(Wyngaardt et al., 2004)\" isShortName></Paper>. This rapid development capability makes phage display particularly valuable for responding to emerging infectious disease outbreaks, such as SARS coronavirus or avian influenza, where quick diagnostic solutions are critical <Paper corpusId=\"35348531\" paperTitle=\"(Chan et al., 2011)\" isShortName></Paper>.\n\nFurthermore, phage display simplifies production processes. Unlike traditional monoclonal antibodies that require specialized cell culture facilities for hybridoma cell lines, recombinant antibody fragments can be propagated in bacteria such as E. coli, significantly reducing production costs <Paper corpusId=\"198254683\" paperTitle=\"(Peltomaa et al., 2019)\" isShortName></Paper> <Paper corpusId=\"11867879\" paperTitle=\"(Byrne et al., 2009)\" isShortName></Paper>. The technology also allows for an entirely in vitro process, eliminating the need for animal immunization and cell culture-based production systems, which streamlines manufacturing and improves scalability <Paper corpusId=\"268017705\" paperTitle=\"(Zhang et al., 2024)\" isShortName></Paper>.\n\nPhage display offers impressive library diversity advantages as well. The technology enables the creation of libraries containing billions of different antibody clones, from which specific binders can be isolated through recursive selection cycles <Paper corpusId=\"2490199\" paperTitle=\"(Lillo et al., 2011)\" isShortName></Paper>. This approach allows researchers to \"interrogate libraries of millions to tens of billions of antibodies\" based on their specific binding properties\u2014a scale that would be \"unfathomable in traditional hybridoma work\" <Paper corpusId=\"4771464\" paperTitle=\"(Finlay et al., 2016)\" isShortName></Paper>.\n\nAn additional production benefit is the flexibility of recombinant antibodies for customization and modification. This adaptability is particularly valuable for diagnostic applications, allowing antibodies to evolve alongside advancements in sensing technologies <Paper corpusId=\"55838761\" paperTitle=\"(Ch'ng et al., 2016)\" isShortName></Paper>. Some studies have even found that antibodies generated through phage display demonstrate greater sensitivity toward antigens compared to those produced through traditional techniques <Paper corpusId=\"270748518\" paperTitle=\"(Sadraeian et al., 2024)\" isShortName></Paper>.", "citations": [{"id": "(McIvor et al., 2013)", "paper": {"corpus_id": 10496834, "title": "Phage Display-Derived Binders Able to Distinguish Listeria monocytogenes from Other Listeria Species", "year": 2013, "venue": "PLoS ONE", "authors": [{"name": "M. J. McIvor", "authorId": "2124972713"}, {"name": "N. Karoonuthaisiri", "authorId": "6141448"}, {"name": "Ratthaphol Charlermroj", "authorId": "3555986"}, {"name": "L. Stewart", "authorId": "153497667"}, {"name": "C. Elliott", "authorId": "145480579"}, {"name": "I. Grant", "authorId": "4318116"}], "n_citations": 22}, "snippets": ["Development of animal derived antibodies is not an easy task and they are expensive to produce. In addition efforts are ongoing to reduce, refine and replace the use of animals in scientific research in accordance with EU legislation, Directive 2010/63/EU [21]. Phage display biopanning is a technique extending from the invention of phage display technology in 1985 (Smith, 1985) and offers an alternative means of generating specific affinity ligands."], "score": 0.91455078125}, {"id": "(Smith, 1985)", "paper": {"corpus_id": 9420027, "title": "Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.", "year": 1985, "venue": "Science", "authors": [{"name": "G. P. Smith", "authorId": "2254711382"}], "n_citations": 3900}, "snippets": ["Foreign DNA fragments can be inserted into filamentous phage gene III to create a fusion protein with the foreign sequence in the middle. The fusion protein is incorporated into the virion, which retains infectivity and displays the foreign amino acids in immunologically accessible form. These \"fusion phage\" can be enriched more than 1000-fold over ordinary phage by affinity for antibody directed against the foreign sequence. Fusion phage may provide a simple way of cloning a gene when an antibody against the product of that gene is available."], "score": 0.0}, {"id": "(Ferrara et al., 2012)", "paper": {"corpus_id": 14579386, "title": "Using Phage and Yeast Display to Select Hundreds of Monoclonal Antibodies: Application to Antigen 85, a Tuberculosis Biomarker", "year": 2012, "venue": "PLoS ONE", "authors": [{"name": "F. Ferrara", "authorId": "46773024"}, {"name": "L. Naranjo", "authorId": "4899598"}, {"name": "Sandeep Kumar", "authorId": "2109726524"}, {"name": "T. Gaiotto", "authorId": "5348591"}, {"name": "H. Mukundan", "authorId": "2215428"}, {"name": "B. Swanson", "authorId": "47630416"}, {"name": "A. Bradbury", "authorId": "145028383"}], "n_citations": 76}, "snippets": ["The monoclonal antibodies (mAbs) identified in this way show high binding affinity and selectivity for the antigens and offer an advantage over traditional mAbs produced by relatively expensive and time consuming techniques."], "score": 0.9619140625}, {"id": "(Anand et al., 2021)", "paper": {"corpus_id": 232158116, "title": "Phage Display Technique as a Tool for Diagnosis and Antibody Selection for Coronaviruses", "year": 2021, "venue": "Current Microbiology", "authors": [{"name": "T. Anand", "authorId": "145780422"}, {"name": "N. Virmani", "authorId": "5330684"}, {"name": "B. C. Bera", "authorId": "48377477"}, {"name": "R. Vaid", "authorId": "32133171"}, {"name": "M. Vashisth", "authorId": "28295056"}, {"name": "Priyanka Bardajatya", "authorId": "2052184685"}, {"name": "Ashok Kumar", "authorId": "2118070220"}, {"name": "B. N. Tripathi", "authorId": "38216015"}], "n_citations": 48}, "snippets": ["Major advantages of antibody phage display include as follows: production of large-sized combinatorial libraries, improved efficiency than conventional hybridoma system, easy manipulation, safety, no involvement of animal cell culture, lower propagative cost and easy screening procedures involved to select target specific binders (Bazan et al., 2012)(Pande et al., 2010)(Ledsgaard et al., 2018). Specifically for viral pathogens, antibody phage display is an alternative tool to hybridoma technology, since it circumvents the limitations of the immune system (Aghebati-Maleki et al., 2016)."], "score": 0.931640625}, {"id": "(Chitray et al., 2020)", "paper": {"corpus_id": 221092042, "title": "Diagnostic and Epitope Mapping Potential of Single-Chain Antibody Fragments Against Foot-and-Mouth Disease Virus Serotypes A, SAT1, and SAT3", "year": 2020, "venue": "Frontiers in Veterinary Science", "authors": [{"name": "M. Chitray", "authorId": "5302796"}, {"name": "P. Opperman", "authorId": "2989445"}, {"name": "L. Rotherham", "authorId": "4832935"}, {"name": "J. Fehrsen", "authorId": "5655837"}, {"name": "W. van Wyngaardt", "authorId": "34187782"}, {"name": "J. Frischmuth", "authorId": "3064213"}, {"name": "E. Rieder", "authorId": "46914821"}, {"name": "F. Maree", "authorId": "2413984"}], "n_citations": 5}, "snippets": ["A key advantage of phage display of antibody fragments is that the generation of specific singlechain variable fragment (scFv) or antigen binding fragment (Fab) to a particular antigen can be completed within a few weeks compared to hybridomas taking months. Antibody libraries can be either immune (from immunized donors) or na\u00efve (from non-immunized donors). An immune library will have an antibody range that is highly enriched for antibodies generated in response to a particular immunogen, whereas, the na\u00efve library can advantageously be used for an unlimited array of immunogens (Wyngaardt et al., 2004)."], "score": 0.9833984375}, {"id": "(Wyngaardt et al., 2004)", "paper": {"corpus_id": 6845760, "title": "A large semi-synthetic single-chain Fv phage display library based on chicken immunoglobulin genes", "year": 2004, "venue": "BMC Biotechnology", "authors": [{"name": "W. van Wyngaardt", "authorId": "34187782"}, {"name": "Teresiah Malatji", "authorId": "50694454"}, {"name": "Cordelia Mashau", "authorId": "5236048"}, {"name": "J. Fehrsen", "authorId": "5655837"}, {"name": "F. Jordaan", "authorId": "5938544"}, {"name": "Dubravka R Miltiadou", "authorId": "40459030"}, {"name": "D. D. du Plessis", "authorId": "6056643"}], "n_citations": 63}, "snippets": ["BackgroundAntibody fragments selected from large combinatorial libraries have numerous applications in diagnosis and therapy. Most existing antibody repertoires are derived from human immunoglobulin genes. Genes from other species can, however, also be used. Because of the way in which gene conversion introduces diversity, the na\u00efve antibody repertoire of the chicken can easily be accessed using only two sets of primers.ResultsWith in vitro diagnostic applications in mind, we have constructed a large library of recombinant filamentous bacteriophages displaying single chain antibody fragments derived from combinatorial pairings of chicken variable heavy and light chains. Synthetically randomised complementarity determining regions are included in some of the heavy chains. Single chain antibody fragments that recognise haptens, proteins and virus particles were selected from this repertoire. Affinities of three different antibody fragments were determined using surface plasmon resonance. Two were in the low nanomolar and one in the subnanomolar range. To illustrate the practical value of antibodies from the library, phage displayed single chain fragments were incorporated into ELISAs aimed at detecting African horsesickness and bluetongue virus particles. Virus antibodies were detected in a competitive ELISA.ConclusionThe chicken-derived phage library described here is expected to be a versatile source of recombinant antibody fragments directed against a wide variety of antigens. It has the potential to provide monoclonal reagents with applications in research and diagnostics. For in vitro applications, na\u00efve phage libraries based on avian donors may prove to be useful adjuncts to the selectable antibody repertoires that already exist."], "score": 0.0}, {"id": "(Chan et al., 2011)", "paper": {"corpus_id": 35348531, "title": "Comparison of the efficiency of antibody selection from semi-synthetic scFv and non-immune Fab phage display libraries against protein targets for rapid development of diagnostic immunoassays", "year": 2011, "venue": "JIM - Journal of Immunological Methods", "authors": [{"name": "Conrad E. Z. Chan", "authorId": "37861577"}, {"name": "A. H. Chan", "authorId": "153748718"}, {"name": "A. P. Lim", "authorId": "3988285"}, {"name": "B. Hanson", "authorId": "6494284"}], "n_citations": 50}, "snippets": ["The rapidity of this technique makes it ideal for generating novel antibodies for diagnostic and potentially therapeutic responses to outbreaks of emerging infectious disease such as SARS coronavirus and H5N1 Avian Influenza or genetically modified pathogens released in a bioterrorism incident. Since antibodies are highly specific and are capable of recognizing virtually every class of pathogen, including toxins, viruses, bacteria and fungi, they enable easy and rapid identification of pathogens (Nowakowski et al., 2002)(Hayhurst et al., 2003)(Paoli et al., 2004)(Steiniger et al., 2007)(Cabezas et al., 2008)."], "score": 0.9267578125}, {"id": "(Peltomaa et al., 2019)", "paper": {"corpus_id": 198254683, "title": "Phage Display in the Quest for New Selective Recognition Elements for Biosensors", "year": 2019, "venue": "ACS Omega", "authors": [{"name": "Riikka Peltomaa", "authorId": "3554578"}, {"name": "E. Benito-Pe\u00f1a", "authorId": "1401480712"}, {"name": "R. Barderas", "authorId": "5941973"}, {"name": "M. Moreno-Bondi", "authorId": "1398106433"}], "n_citations": 73}, "snippets": ["Moreover, unlike full-length antibodies, recombinant antibody fragments can be propagated in bacteria, such as E. coli, which significantly lower the cost of production as no specialized cell culture facilities for hybridoma cell lines are needed. (Byrne et al., 2009)(Charlton, 2004) On the other hand, phage display also offers the possibility of selecting various other bioinspired recognition elements, (Peltomaa et al., 2017) such as peptides or other binding proteins and scaffolds, which might provide further advantages compared to antibodies. In vitro selections by phage display facilitates the production of novel receptors beyond known biomolecular interactions, or against toxic or nonimmunogenic targets, or even using whole cells as the target. 1"], "score": 0.927734375}, {"id": "(Byrne et al., 2009)", "paper": {"corpus_id": 11867879, "title": "Antibody-Based Sensors: Principles, Problems and Potential for Detection of Pathogens and Associated Toxins", "year": 2009, "venue": "Italian National Conference on Sensors", "authors": [{"name": "B. Byrne", "authorId": "145734208"}, {"name": "E. Stack", "authorId": "35157782"}, {"name": "N. Gilmartin", "authorId": "6889038"}, {"name": "R. O\u2019Kennedy", "authorId": "11755579"}], "n_citations": 346}, "snippets": ["Antibody-based sensors permit the rapid and sensitive analysis of a range of pathogens and associated toxins. A critical assessment of the implementation of such formats is provided, with reference to their principles, problems and potential for \u2018on-site\u2019 analysis. Particular emphasis is placed on the detection of foodborne bacterial pathogens, such as Escherichia coli and Listeria monocytogenes, and additional examples relating to the monitoring of fungal pathogens, viruses, mycotoxins, marine toxins and parasites are also provided."], "score": 0.0}, {"id": "(Zhang et al., 2024)", "paper": {"corpus_id": 268017705, "title": "Monoclonal Antibody Development for Cancer Treatment Using the Phage Display Library Platform", "year": 2024, "venue": "Biologics", "authors": [{"name": "Tiantian Zhang", "authorId": "2146334211"}, {"name": "Zhe Wang", "authorId": "2287087475"}], "n_citations": 1}, "snippets": ["This enables the identification of antibodies with superior binding properties compared to those obtained through traditional hybridoma-based methods (Moraes et al., 2021). Additionally, phage display offers greater versatility in antibody engineering, allowing for the incorporation of specific modifications, such as humanization or affinity maturation, to improve therapeutic efficacy and reduce immunogenicity. Moreover, phage display-derived antibodies offer potential benefits in terms of manufacturing scalability and cost effectiveness. Unlike traditional mAbs produced from hybridoma cell lines, phage-derived antibodies can be generated entirely in vitro, eliminating the need for animal immunization and cell culture-based production systems. This streamlined production process enables rapid and cost-effective antibody development, making phage display an attractive platform for the generation of therapeutic antibodies [22]."], "score": 0.9326171875}, {"id": "(Lillo et al., 2011)", "paper": {"corpus_id": 2490199, "title": "Development of Phage-Based Single Chain Fv Antibody Reagents for Detection of Yersinia pestis", "year": 2011, "venue": "PLoS ONE", "authors": [{"name": "A. Lillo", "authorId": "50680211"}, {"name": "J. Ayriss", "authorId": "6514033"}, {"name": "Y. Shou", "authorId": "6396708"}, {"name": "S. Graves", "authorId": "2344721"}, {"name": "A. Bradbury", "authorId": "145028383"}], "n_citations": 40}, "snippets": ["In recent years, antibody phage display has become a very popular method to isolate specific antibodies, bypassing hybridoma technology and even the need for immunization. In general, libraries are made up of either single chain Fv (scFv) or Fab fragments, and comprise billions of different clones, from which specific binders can be isolated by recursive selection cycles. One of the advantages of using phage antibody libraries is that several antibody fragments, binding to different epitopes, are usually selected, providing a greater likelihood that useful binders will be obtained."], "score": 0.90234375}, {"id": "(Finlay et al., 2016)", "paper": {"corpus_id": 4771464, "title": "Phage Display: A Powerful Technology for the Generation of High-Specificity Affinity Reagents from Alternative Immune Sources", "year": 2016, "venue": "Methods in molecular biology", "authors": [{"name": "W. Finlay", "authorId": "49314099"}, {"name": "L. Bloom", "authorId": "2139474"}, {"name": "Joanne Grant", "authorId": "145488033"}, {"name": "E. Franklin", "authorId": "49424893"}, {"name": "Deirdre N\u00ed Sh\u00failleabh\u00e1in", "authorId": "10345007"}, {"name": "O. Cunningham", "authorId": "143870849"}], "n_citations": 18}, "snippets": ["To bypass the limitations in polyclonal and monoclonal antibody generation, several groups have turned to in vitro display technologies such as phage display, ribosome display, or yeast display libraries to generate recombinant antibodies. The more recent technologies of yeast and ribosome display are becoming highly established, but phage display is currently the most robust, well characterized, and reliable of these methods. Antibodies derived from these technologies are cloned in microbial hosts and are therefore monoclonal from the start, with their production being easily scaled up. Critically, selection and screening efforts can be directed toward specifi c epitopes or species cross-reactivity and away from polyspecifi c binding. Phage display allows a researcher to do in a single tube what would be unfathomable in traditional hybridoma work: interrogate libraries of millions to tens of billions of antibodies on the basis of their binding specifi cally to a target of interest."], "score": 0.880859375}, {"id": "(Ch'ng et al., 2016)", "paper": {"corpus_id": 55838761, "title": "Phage Display\u2010Derived Antibodies: Application of Recombinant Antibodies for Diagnostics", "year": 2016, "venue": "", "authors": [{"name": "Angela Chiew Wen Ch\u2019ng", "authorId": "1412157815"}, {"name": "Y. Choong", "authorId": "2158170"}, {"name": "T. S. Lim", "authorId": "1734088"}], "n_citations": 12}, "snippets": ["The ability to produce antibodies via recombinant methods can help to improve the speed at which newer antibodies are produced at a fraction of the conventional cost. The freedom associated with recombinant antibodies would also allow the customization of antibodies for various downstream applications in diagnostics. This is particularly important as the development of newer technologies in sensing and reporting mechanisms, the flexibility of recombinant antibodies towards modifications would allow the antibodies to evolve with the advancement of sensing technologies."], "score": 0.94091796875}, {"id": "(Sadraeian et al., 2024)", "paper": {"corpus_id": 270748518, "title": "Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases", "year": 2024, "venue": "Molecules", "authors": [{"name": "Mohammad Sadraeian", "authorId": "9917727"}, {"name": "Reza Maleki", "authorId": "2296344766"}, {"name": "Mahta Moraghebi", "authorId": "1659475048"}, {"name": "Abasalt Bahrami", "authorId": "2262937686"}], "n_citations": 5}, "snippets": ["Since this technology comprises an in vitro screening procedure, it has eliminated the limitations and constraints of hybridoma technology [25]", "Although generating monoclonal antibodies is both an expensive and time-consuming task, they are widely deployed in immunological tests. In contrast, phage display allows for the quick collection of recombinant antibodies at a low cost and with the same affinity. Furthermore, in certain investigations, antibodies generated through phage display were more sensitive toward an antigen compared to other traditional techniques. A peptide that binds the spike protein of the transmissible gastroenteritis virus (TGEV) was developed by Suo and colleagues using phage display for diagnostic purposes. It was discovered that phage-mediated ELISA was more sensitive than conventional antibody-based ELISA [27]."], "score": 0.9150390625}], "table": null}, {"title": "Technical Advantages", "tldr": "Phage display-derived antibodies offer superior technical characteristics including smaller size, higher stability, and customizable structure compared to traditional antibodies. These properties enable better target recognition, improved signal amplification, and enhanced adaptability to various diagnostic platforms. (11 sources)", "text": "\nPhage display technology produces antibody fragments with distinct technical advantages over traditional antibodies. One significant benefit is their reduced molecular size. Single chain fragment variables (scFvs) generated through phage display are considerably smaller than conventional antibodies, overcoming size limitations that can affect diagnostic applications <Paper corpusId=\"269059585\" paperTitle=\"(Zheng et al., 2024)\" isShortName></Paper>. This smaller footprint allows phage-derived antibodies to access epitopes that might be inaccessible to larger traditional antibodies <Paper corpusId=\"201228624\" paperTitle=\"(Qiu et al., 2019)\" isShortName></Paper>.\n\nThe structural stability of phage-derived antibodies represents another crucial technical advantage. Unlike conventional antibodies, phage antibodies demonstrate remarkable stability, often lacking disulfide bonds that can be vulnerable to environmental conditions <Paper corpusId=\"271163341\" paperTitle=\"(Guliy et al., 2024)\" isShortName></Paper>. This enhanced stability translates to better performance in various diagnostic conditions, potentially extending shelf-life and improving reliability <Paper corpusId=\"275841635\" paperTitle=\"(Kasana et al., 2025)\" isShortName></Paper> <Paper corpusId=\"38116085\" paperTitle=\"(Shukra et al., 2014)\" isShortName></Paper>.\n\nPhage display technology also offers unique signal amplification capabilities. For instance, M13 filamentous phages contain approximately 2,700 copies of the major pVIII coat protein per particle, which can be leveraged for significant signal enhancement when using reporter-conjugated anti-M13 antibodies <Paper corpusId=\"201228624\" paperTitle=\"(Qiu et al., 2019)\" isShortName></Paper>. This built-in amplification mechanism gives phage-displayed antibodies a distinct advantage in diagnostic sensitivity.\n\nAnother key technical benefit is the direct access to the genetic information of the binding molecule. This genetic accessibility allows for rapid adaptation of antibody formats to suit specific diagnostic assays, including IgG, scFv-Fc, biotinylated antibodies, or fusion proteins <Paper corpusId=\"44841738\" paperTitle=\"(Schirrmann et al., 2011)\" isShortName></Paper>. This flexibility enables researchers to optimize antibody structure for particular detection platforms.\n\nPhage-displayed antigens also offer advantages in detecting structural epitopes. Unlike linear peptide displays, recombinant antigens on phage surfaces can maintain proper folding and stable structures, allowing for interaction with antibodies that recognize conformational epitopes <Paper corpusId=\"251712361\" paperTitle=\"(Chen et al., 2022)\" isShortName></Paper>. Additionally, polyvalent display systems can reduce nonspecific binding, enhancing the specificity of diagnostic assays <Paper corpusId=\"251712361\" paperTitle=\"(Chen et al., 2022)\" isShortName></Paper>.\n\nIn practical applications, landscape-phage-based interfaces have demonstrated superior performance compared to natural immunoglobulin counterparts in various detector platforms <Paper corpusId=\"46974853\" paperTitle=\"(Petrenko, 2018)\" isShortName></Paper> <Paper corpusId=\"9192594\" paperTitle=\"(Petrenko et al., 2000)\" isShortName></Paper>. These phage-derived antibodies can bind protein and glycoprotein antigens with nanomolar affinities and high specificity, while being more convenient than traditional antibodies in many aspects <Paper corpusId=\"46974853\" paperTitle=\"(Petrenko, 2018)\" isShortName></Paper> <Paper corpusId=\"9192594\" paperTitle=\"(Petrenko et al., 2000)\" isShortName></Paper>.\n\nMoreover, phage-scFvs offer additional practical advantages including ease of purification and labeling compared to free scFvs <Paper corpusId=\"47191392\" paperTitle=\"(Lillo et al., 2012)\" isShortName></Paper>. The phage display selection process typically yields multiple antibody fragments binding to different epitopes, increasing the likelihood of obtaining useful binders for diagnostic applications <Paper corpusId=\"47191392\" paperTitle=\"(Lillo et al., 2012)\" isShortName></Paper>.\n\nThe combination of low molecular weight, high stability, and in vitro production makes phage-like antibodies particularly valuable for biosensor applications. For example, phage display antibodies have been successfully used to detect pathogens like Listeria monocytogenes in surface plasmon resonance (SPR) biosensors, demonstrating the promise of these non-traditional recognition elements <Paper corpusId=\"265444141\" paperTitle=\"(Guliy et al., 2023)\" isShortName></Paper>.", "citations": [{"id": "(Zheng et al., 2024)", "paper": {"corpus_id": 269059585, "title": "Advancement in the development of single chain antibodies using phage display technology", "year": 2024, "venue": "PeerJ", "authors": [{"name": "Xiaohui Zheng", "authorId": "2296638822"}, {"name": "Qi Liu", "authorId": "2296081826"}, {"name": "Yimin Liang", "authorId": "2219050584"}, {"name": "Wenzhi Feng", "authorId": "2296254322"}, {"name": "Honghao Yu", "authorId": "2296458106"}, {"name": "C. Tong", "authorId": "1669905334"}, {"name": "Bocui Song", "authorId": "7992703"}], "n_citations": 2}, "snippets": ["Using phage display technology, single chain fragment variable (scFv) can be screened, replacing the disadvantage of the large size of traditional antibodies."], "score": 0.8876953125}, {"id": "(Qiu et al., 2019)", "paper": {"corpus_id": 201228624, "title": "Phage-displayed nanobody based double antibody sandwich chemiluminescent immunoassay for the detection of Cry2A toxin in cereals", "year": 2019, "venue": "Food and Agricultural Immunology", "authors": [{"name": "Yulou Qiu", "authorId": "12702841"}, {"name": "Pan Li", "authorId": "1798143258"}, {"name": "Beibei Liu", "authorId": "2108662168"}, {"name": "Yuan Liu", "authorId": "2143860177"}, {"name": "Yulong Wang", "authorId": "2115663670"}, {"name": "Tingting Tao", "authorId": "47361440"}, {"name": "Junli Xu", "authorId": "2150635918"}, {"name": "B. Hammock", "authorId": "3767289"}, {"name": "Xianjin Liu", "authorId": "8016566"}, {"name": "Rongfa Guan", "authorId": "37298327"}, {"name": "Cunzheng Zhang", "authorId": "4684238"}], "n_citations": 14}, "snippets": ["Compared with conventional antibodies, nanobodies have high stability, high affinity, the advantages of easy to produce, and can recognize inaccessible epitopes", "Moreover, phage-displayed nanobodies can provide an advantage over the soluble nanobodies being used as reporter elements for immunoassays development. For example, M13 phage particles contain approximately 2700 copies of pVIII capsid protein per phage. This can be used for signal amplification and modification", "When compared with the traditional antibodies or soluble nanobodies, phage-displayed nanobodies have the advantages of ease of production, reproducibility and lowcost. Besides, M13 filamentous phages, which have \u223c2700 copies of the 5 kD major pVIII coat protein, can provide great signal amplification when using reporter-conjugated anti-M13 pVIII antibodies."], "score": 0.94091796875}, {"id": "(Guliy et al., 2024)", "paper": {"corpus_id": 271163341, "title": "Phage Antibodies for Detection of Diagnostically Important Antigens.", "year": 2024, "venue": "Frontiers in Bioscience", "authors": [{"name": "O. Guliy", "authorId": "3738457"}, {"name": "V. A. Khanadeev", "authorId": "2283420197"}, {"name": "L. Dykman", "authorId": "34641005"}], "n_citations": 3}, "snippets": ["Phage Abs are an excellent alternative to mono- and polyclonal Abs, because they are highly stable, have no disulfide bonds, and are much cheaper to make", ".Many studies have confirmed that unlike other types of Abs, phage Abs ensure highly sensitive Ag detection."], "score": 0.94677734375}, {"id": "(Kasana et al., 2025)", "paper": {"corpus_id": 275841635, "title": "Monoclonal antibodies for diagnosis of viral diseases: a comprehensive review", "year": 2025, "venue": "Journal of Applied Biology &amp; Biotechnology", "authors": [{"name": "Abhishek Kasana", "authorId": "2319120873"}, {"name": "Aishwarya Dwivedi", "authorId": "2341743777"}, {"name": "Vaishali Verma", "authorId": "2319121406"}], "n_citations": 0}, "snippets": ["Recombinant monoclonal antibodies developed using phage display offer several advantages over traditional hybridoma-derived antibodies [Table 2]. These include improved stability, consistent quality, and the ability to engineer desired properties like higher affinity or specificity (Shukra et al., 2014)."], "score": 0.96044921875}, {"id": "(Shukra et al., 2014)", "paper": {"corpus_id": 38116085, "title": "Production of recombinant antibodies using bacteriophages.", "year": 2014, "venue": "European Journal of Microbiology & Immunology", "authors": [{"name": "A. Shukra", "authorId": "14600374"}, {"name": "N. Sridevi", "authorId": "32401337"}, {"name": "D. Chandran", "authorId": "3326101"}, {"name": "K. Maithal", "authorId": "48849114"}], "n_citations": 34}, "snippets": ["Recombinant antibody fragments such as Fab, scFv, diabodies, triabodies, single domain antibodies and minibodies have recently emerged as potential alternatives to monoclonal antibodies, which can be engineered using phage display technology. These antibodies match the strengths of conventionally produced monoclonal antibodies and offer advantages for the development of immunodiagnostic kits and assays. These fragments not only retain the specificity of the whole monoclonal antibodies but also easy to express and produce in prokaryotic expression system. Further, these antibody fragments are genetically stable, less expensive, easy to modify in response to viral mutations and safer than monoclonal antibodies for use in diagnostic and therapeutic applications. This review describes the potential of antibody fragments generated using phage display and their use as diagnostic reagents."], "score": 0.0}, {"id": "(Schirrmann et al., 2011)", "paper": {"corpus_id": 44841738, "title": "Phage Display for the Generation of Antibodies for Proteome Research, Diagnostics and Therapy", "year": 2011, "venue": "Molecules", "authors": [{"name": "T. Schirrmann", "authorId": "6511832"}, {"name": "Torsten Meyer", "authorId": "2068147527"}, {"name": "Mark Sch\u00fctte", "authorId": "40196344"}, {"name": "A. Frenzel", "authorId": "3909598"}, {"name": "M. Hust", "authorId": "6956173"}], "n_citations": 111}, "snippets": ["A big advantage of antibody phage display for diagnostics is the direct access to the genetic information of the binder, allowing a fast adaption of the antibody format e.g., IgG, scFv-Fc, biotinylated antibody or scFv-phoA fusion (Hust et al., 2011) to the desired diagnostic assay."], "score": 0.9189453125}, {"id": "(Chen et al., 2022)", "paper": {"corpus_id": 251712361, "title": "Simultaneous measurement of the antibody responses against SARS-CoV-2 and its multiple variants by a phage display mediated immuno-multiplex quantitative PCR-based assay", "year": 2022, "venue": "Frontiers in Microbiology", "authors": [{"name": "Hanyi Chen", "authorId": "2118024271"}, {"name": "Shen Li", "authorId": "144103688"}, {"name": "Jiali Wang", "authorId": "1685265244"}, {"name": "Siqi He", "authorId": "2109380953"}, {"name": "Dong Wang", "authorId": "2152690746"}, {"name": "Zhaohui Qian", "authorId": "5090467"}, {"name": "Dandan Hu", "authorId": "1744873516"}, {"name": "Fangfang Qi", "authorId": "91170750"}, {"name": "Keping Hu", "authorId": "49215539"}, {"name": "C. Luo", "authorId": "90790575"}, {"name": "Jianxun Wang", "authorId": "2144507213"}], "n_citations": 4}, "snippets": ["Compared with linear peptides, the recombinant antigens displayed on the phage surface have shown some function that requires the correct folding to form a stable structure, and the binding efficiency between the recombinant phage and existing antibodies is reduced by mutations on antigens known to be important for antigen\u2013antibody interaction", "the phage-displayed antigen can be used not only to detect lineardirected antibodies but also in some research that requires the correct structure", "compared with this, the polyvalent display system can reduce nonspecific binding and has more advantages in diagnostic assays."], "score": 0.87841796875}, {"id": "(Petrenko, 2018)", "paper": {"corpus_id": 46974853, "title": "Landscape Phage: Evolution from Phage Display to Nanobiotechnology", "year": 2018, "venue": "Viruses", "authors": [{"name": "V. Petrenko", "authorId": "145050550"}], "n_citations": 42}, "snippets": ["Landscape-phage-based interfaces performed in many ways much more effectively than their natural immunoglobulin counterparts in the same detector platforms. Target-specific landscape-phage probes can be prepared as described in commonly available protocols [58](Brigati et al., 2008)", "Most analytic platforms rely on the use of monoclonal antibodies as biorecognition probes. However, their broad application is limited by high cost, low specificity, less-than-optimal affinity, and sensitivity to environmental stresses. Landscape-phage display is a novel concept that allows for the development of diagnostic and detection interfaces that meet modern criteria for biological detection and monitoring (Petrenko, 2008)21,(Petrenko et al., 2000)(Petrenko et al., 2004)(Petrenko et al., 2003)."], "score": 0.9169921875}, {"id": "(Petrenko et al., 2000)", "paper": {"corpus_id": 9192594, "title": "Phages from landscape libraries as substitute antibodies.", "year": 2000, "venue": "Protein Engineering", "authors": [{"name": "Valery A. Petrenko", "authorId": "2259462628"}, {"name": "George P. Smith", "authorId": "2253030563"}], "n_citations": 136}, "snippets": ["In 'landscape' phage, as in traditional phage-display constructs, foreign peptides or proteins are fused to coat proteins on the surface of a filamentous phage particle. Unlike conventional constructs, however, each virion displays thousands of copies of the peptide in a repeating pattern, subtending a major fraction of the viral surface. The phage body serves as an interacting scaffold to constrain the peptide into a particular conformation, creating a defined organic surface structure ('landscape') that varies from one phage clone to the next. By testing landscape libraries with three representative antigens (streptavidin from the bacterium Streptomyces avidinii, avidin from chicken egg white and beta-galactosidase from Escherichia coli) we have shown that landscape phages may be used as a new type of substitute antibodies-filaments that can bind protein and glycoprotein antigens with nanomolar affinities and high specificity. In many ways these substitute antibodies are more convenient than their natural immunoglobulin counterparts."], "score": 0.0}, {"id": "(Lillo et al., 2012)", "paper": {"corpus_id": 47191392, "title": "Correction: Development of Phage-Based Single Chain Fv Antibody Reagents for Detection of Yersinia pestis", "year": 2012, "venue": "PLoS ONE", "authors": [{"name": "A. Lillo", "authorId": "50680211"}, {"name": "J. Ayriss", "authorId": "6514033"}, {"name": "Y. Shou", "authorId": "6396708"}, {"name": "S. Graves", "authorId": "2344721"}, {"name": "A. Bradbury", "authorId": "145028383"}, {"name": "P. Pavl\u00edk", "authorId": "2033123"}], "n_citations": 2}, "snippets": ["In recent years, antibody phage display has become a very popular method to isolate specific antibodies, bypassing hybridoma technology and even the need for immunization", "One of the advantages of using phage antibody libraries is that several antibody fragments, binding to different epitopes, are usually selected, providing a greater likelihood that useful binders will be obtained", "Phage-scFvs have a number of advantages over the use of free scFvs, including stability, ease of purification and labeling. Furthermore even our weakest aF1 scFv shows binding specificity in a phage display format."], "score": 0.90478515625}, {"id": "(Guliy et al., 2023)", "paper": {"corpus_id": 265444141, "title": "Optical Sensors for Bacterial Detection", "year": 2023, "venue": "Italian National Conference on Sensors", "authors": [{"name": "O. Guliy", "authorId": "3738457"}, {"name": "O. Karavaeva", "authorId": "6043533"}, {"name": "Andrey Smirnov", "authorId": "2307813476"}, {"name": "S. A. Eremin", "authorId": "2268221008"}, {"name": "V. Bunin", "authorId": "40456403"}], "n_citations": 17}, "snippets": ["Phage-like antibodies have advantages such as in vitro production, a low cost, a low molecular weight, and high stability (Nanduri et al., 2007). Phage display antibodies have been used to detect Listeria monocytogenes in an SPR biosensor (detection limit, 2 \u00d7 10 6 CFU/mL), which indicates the promise of non-antibody recognition elements (Nanduri et al., 2007)."], "score": 0.8779296875}], "table": null}, {"title": "Specificity and Versatility", "tldr": "Phage display-derived antibodies offer exceptional specificity for distinguishing between closely related pathogens and can target conserved epitopes across pathogen variants. This technology allows for the development of antibodies against difficult targets and enables customized modifications for specific diagnostic applications. (12 sources)", "text": "\nPhage display technology enables the development of antibodies with remarkable specificity, capable of distinguishing between closely related pathogens with minute differences. Researchers have demonstrated that phage-derived antibodies can differentiate between proteins that differ by just a single surface amino acid, such as chicken and quail lysozyme, and can distinguish between the SH2 domains of ABL1 and ABL2 <Paper corpusId=\"3943328\" paperTitle=\"(Bradbury et al., 2011)\" isShortName></Paper>. This exquisite specificity is particularly valuable for infectious disease diagnostics, where antibodies must reliably discriminate between different strains of pathogens including Hantavirus, Dengue virus, influenza, Ebola, and Venezuelan equine encephalitis virus <Paper corpusId=\"3943328\" paperTitle=\"(Bradbury et al., 2011)\" isShortName></Paper> <Paper corpusId=\"13478700\" paperTitle=\"(Lim et al., 2008)\" isShortName></Paper> <Paper corpusId=\"30032429\" paperTitle=\"(Meissner et al., 2002)\" isShortName></Paper> <Paper corpusId=\"52808209\" paperTitle=\"(Kirsch et al., 2008)\" isShortName></Paper>.\n\nA significant advantage of phage display technology is its ability to identify antibodies against conserved epitopes shared across different pathogen variants. This capability is particularly valuable for developing diagnostic tests that can detect a wide range of pathogen strains <Paper corpusId=\"259311093\" paperTitle=\"(Palma, 2023)\" isShortName></Paper> <Paper corpusId=\"252560852\" paperTitle=\"(Zhou et al., 2022)\" isShortName></Paper>. For instance, researchers have isolated human monoclonal antibody fragments that react with immunodominant epitopes conserved across multiple viral subtypes, as demonstrated with Ebola virus nucleoprotein <Paper corpusId=\"30032429\" paperTitle=\"(Meissner et al., 2002)\" isShortName></Paper>.\n\nPhage display technology also offers remarkable versatility in target selection, allowing the generation of antibodies against nearly any target, including toxins, pathogens, non-immunogenic, or highly conserved antigens <Paper corpusId=\"3943328\" paperTitle=\"(Bradbury et al., 2011)\" isShortName></Paper>. This versatility extends to the ability to identify mimotopes\u2014peptides that mimic structural epitopes\u2014without requiring amino acid similarity with the original antigen <Paper corpusId=\"14872120\" paperTitle=\"(Goulart et al., 2014)\" isShortName></Paper> <Paper corpusId=\"25709339\" paperTitle=\"(Gazarian et al., 2003)\" isShortName></Paper>. Such mimotopes can be used to map immunologically active sites in diverse biomolecules including proteins, carbohydrates, and lipids, or as epitope-mimicking antigens in diagnostic assays <Paper corpusId=\"14872120\" paperTitle=\"(Goulart et al., 2014)\" isShortName></Paper> <Paper corpusId=\"25375064\" paperTitle=\"(Gevorkian et al., 2005)\" isShortName></Paper>.\n\nThe technology provides enormous diversity within a single library and enables the tailoring of monoclonal antibodies with desired properties through various strategies including depletion, guided selection, and biochemical control <Paper corpusId=\"225635372\" paperTitle=\"(Silva et al., 2020)\" isShortName></Paper>. Additionally, phage display offers greater flexibility in antibody engineering, allowing for specific modifications such as humanization or affinity maturation to enhance performance <Paper corpusId=\"268017705\" paperTitle=\"(Zhang et al., 2024)\" isShortName></Paper>.\n\nIn practical diagnostic applications, selected mimetic peptides can be incorporated into various sensor platforms to create simple, specific, sensitive, and low-cost immunodiagnostic tests <Paper corpusId=\"14872120\" paperTitle=\"(Goulart et al., 2014)\" isShortName></Paper> <Paper corpusId=\"35498330\" paperTitle=\"(Goulart et al., 2010)\" isShortName></Paper>. For instance, micro- and nanoparticles coupled with filamentous bacteriophages displaying selected mimotopes can be used in agglutination tests and ELISA assays, amplifying optical detection and improving diagnostic sensitivity <Paper corpusId=\"35498330\" paperTitle=\"(Goulart et al., 2010)\" isShortName></Paper>.", "citations": [{"id": "(Bradbury et al., 2011)", "paper": {"corpus_id": 3943328, "title": "Beyond natural antibodies: the power of in vitro display technologies", "year": 2011, "venue": "Nature Biotechnology", "authors": [{"name": "A. Bradbury", "authorId": "35407321"}, {"name": "S. Sidhu", "authorId": "35234825"}, {"name": "S. D\u00fcbel", "authorId": "4494940"}, {"name": "J. McCafferty", "authorId": "143914265"}], "n_citations": 506}, "snippets": ["Phage display allows the generation of antibodies against nearly any target, including toxins, pathogens, non-immunogenic, or highly conserved antigens. With respect to protein targets, antibodies have been selected with exquisite specificity, differentiating, for example, between chicken and quail lysozyme (Ayriss et al., 2007) that differ by a single surface amino acid, and the SH2 domains of ABL1 and ABL2 69 , (Mersmann et al., 2010) . Phage antibody libraries have been widely used to select antibodies against infectious agents. These include antibodies that discriminate between different strains of Hantavirus 71 , Dengue virus (Cabezas et al., 2009) , influenza (Lim et al., 2008) , (Okada et al., 2010) , Ebola (Meissner et al., 2002) and Venezuelan equine encephalitis virus (Kirsch et al., 2008) . Given that many of these viruses are classified serologically, the ability to select phage antibodies with similar specificities is not surprising, but unlike antibodies generated by immunization, these have the potential to be used therapeutically."], "score": 0.8798828125}, {"id": "(Lim et al., 2008)", "paper": {"corpus_id": 13478700, "title": "Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library", "year": 2008, "venue": "Virology Journal", "authors": [{"name": "A. P. Lim", "authorId": "2053312023"}, {"name": "Conrad E. Z. Chan", "authorId": "37861577"}, {"name": "Steven K K Wong", "authorId": "32117559"}, {"name": "A. H. Chan", "authorId": "153748718"}, {"name": "E. Ooi", "authorId": "120395155"}, {"name": "B. Hanson", "authorId": "6494284"}], "n_citations": 54}, "snippets": ["Identification of neutralizing antibodies with specificity away from the traditional mutation prone antigenic regions, against the conserved regions of hemagglutinin from H5N1 influenza virus has the potential to provide a therapeutic option which can be developed ahead of time in preparation for a possible pandemic due to H5N1 viruses. In this study, we used a combination of panning strategies against the hemagglutinin (HA) of several antigenic distinct H5N1 isolates to bias selection of Fab-phage from a na\u00efve human library away from the antigenic regions of HA, toward the more conserved portions of the protein. All of the identified Fab clones which showed binding to multiple antigenically distinct HA were converted to fully human IgG, and tested for their ability to neutralize the uptake of H5N1-virus like particles (VLP) into MDCK cells. Five of the antibodies which showed binding to the relatively conserved HA2 subunit of HA, exhibited neutralization of H5N1-VLP uptake in a dose dependant manner. The inhibitory effects of these five antibodies were similar to those observed with a previously described neutralizing antibody specific for the 140s antigenic loop present within HA1 and highlight the exciting possibility that these antibodies may be efficacious against multiple H5N1 strains."], "score": 0.0}, {"id": "(Meissner et al., 2002)", "paper": {"corpus_id": 30032429, "title": "Detection of antibodies against the four subtypes of ebola virus in sera from any species using a novel antibody-phage indicator assay.", "year": 2002, "venue": "Virology", "authors": [{"name": "Felix Meissner", "authorId": "2057366619"}, {"name": "T. Maruyama", "authorId": "7828284"}, {"name": "M. Frentsch", "authorId": "7316617"}, {"name": "A. Hessell", "authorId": "4951686"}, {"name": "Luis L. Rodriguez", "authorId": "2113970039"}, {"name": "T. Geisbert", "authorId": "4166826"}, {"name": "P. Jahrling", "authorId": "4421128"}, {"name": "D. Burton", "authorId": "144482154"}, {"name": "P. Parren", "authorId": "144763674"}], "n_citations": 24}, "snippets": ["The natural host for Ebola virus, presumed to be an animal, has not yet been identified despite an extensive search following several major outbreaks in Africa. A straightforward approach used to determine animal contact with Ebola virus is by assessing the presence of specific antibodies in serum. This approach however has been made very difficult by the absence of specific reagents required for the detection of antibodies from the majority of wild animal species. In this study, we isolated a human monoclonal antibody Fab fragment, KZ51, that reacts with an immunodominant epitope on Ebola virus nucleoprotein (NP) that is conserved on all four Ebola virus subtypes. The antibody KZ51 represents a major specificity as sera from all convalescent patients tested (10/10) and sera from guinea pigs infected with each of the four Ebola virus subtypes competed strongly with KZ51 for binding to radiation-inactivated Ebola virus. These features allowed us to develop a novel assay for the detection of seroconversion irrespective of Ebola virus subtype or animal species. In this assay, the binding of KZ51 Fab-phage particles is used as an indicator assay and the presence of specific antibodies against Ebola virus in sera is indicated by binding competition. A prominent feature of the assay is that the Fab-phage particles may be prestained with a dye so that detection of binding can be directly determined by visual inspection. The assay is designed to be both simple and economical to enable its use in the field."], "score": 0.0}, {"id": "(Kirsch et al., 2008)", "paper": {"corpus_id": 52808209, "title": "Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV)", "year": 2008, "venue": "BMC Biotechnology", "authors": [{"name": "M. I. Kirsch", "authorId": "46683624"}, {"name": "B. H\u00fclseweh", "authorId": "5960127"}, {"name": "Christoph Nacke", "authorId": "2246180904"}, {"name": "Torsten R\u00fclker", "authorId": "4726561"}, {"name": "T. Schirrmann", "authorId": "6511832"}, {"name": "H. Marschall", "authorId": "104993230"}, {"name": "M. Hust", "authorId": "6956173"}, {"name": "S. D\u00fcbel", "authorId": "4494940"}], "n_citations": 162}, "snippets": ["BackgroundVenezuelan equine encephalitis virus (VEEV) belongs to the Alphavirus group. Several species of this family are also pathogenic to humans and are recognized as potential agents of biological warfare and terrorism. The objective of this work was the generation of recombinant antibodies for the detection of VEEV after a potential bioterrorism assault or an natural outbreak of VEEV.ResultsIn this work, human anti-VEEV single chain Fragments variable (scFv) were isolated for the first time from a human na\u00efve antibody gene library using optimized selection processes. In total eleven different scFvs were identified and their immunological specificity was assessed. The specific detection of the VEEV strains TC83, H12/93 and 230 by the selected antibody fragments was proved. Active as well as formalin inactivated virus particles were recognized by the selected antibody fragments which could be also used for Western blot analysis of VEEV proteins and immunohistochemistry of VEEV infected cells. The anti-VEEV scFv phage clones did not show any cross-reactivity with Alphavirus species of the Western equine encephalitis virus (WEEV) and Eastern equine encephalitis virus (EEEV) antigenic complex, nor did they react with Chikungunya virus (CHIKV), if they were used as detection reagent.ConclusionFor the first time, this study describes the selection of antibodies against a human pathogenic virus from a human na\u00efve scFv antibody gene library using complete, active virus particles as antigen. The broad and sensitive applicability of scFv-presenting phage for the immunological detection and diagnosis of Alphavirus species was demonstrated. The selected antibody fragments will improve the fast identification of VEEV in case of a biological warfare or terroristic attack or a natural outbreak."], "score": 0.0}, {"id": "(Palma, 2023)", "paper": {"corpus_id": 259311093, "title": "Epitopes and Mimotopes Identification Using Phage Display for Vaccine Development against Infectious Pathogens", "year": 2023, "venue": "Vaccines", "authors": [{"name": "M. Palma", "authorId": "50200818"}], "n_citations": 13}, "snippets": ["Moreover, the utilization of phage display technology allows for the identification of epitopes that are conserved among different strains of a pathogen. This aspect is particularly valuable for developing diagnostic tests capable of detecting a wide range of pathogen variants (Zhou et al., 2022)."], "score": 0.93798828125}, {"id": "(Zhou et al., 2022)", "paper": {"corpus_id": 252560852, "title": "A Promising Tool in Serological Diagnosis: Current Research Progress of Antigenic Epitopes in Infectious Diseases", "year": 2022, "venue": "Pathogens", "authors": [{"name": "Jiahuan Zhou", "authorId": "2155797047"}, {"name": "Jiayi Chen", "authorId": "2108327318"}, {"name": "Yunchi Peng", "authorId": "2186336455"}, {"name": "Yafeng Xie", "authorId": "10372398"}, {"name": "Yongjian Xiao", "authorId": "13357408"}], "n_citations": 9}, "snippets": ["Infectious diseases, caused by various pathogens in the clinic, threaten the safety of human life, are harmful to physical and mental health, and also increase economic burdens on society. Infections are a complex mechanism of interaction between pathogenic microorganisms and their host. Identification of the causative agent of the infection is vital for the diagnosis and treatment of diseases. Etiological laboratory diagnostic tests are therefore essential to identify pathogens. However, due to its rapidity and automation, the serological diagnostic test is among the methods of great significance for the diagnosis of infections with the basis of detecting antigens or antibodies in body fluids clinically. Epitopes, as a special chemical group that determines the specificity of antigens and the basic unit of inducing immune responses, play an important role in the study of immune responses. Identifying the epitopes of a pathogen may contribute to the development of a vaccine to prevent disease, the diagnosis of the corresponding disease, and the determination of different stages of the disease. Moreover, both the preparation of neutralizing antibodies based on useful epitopes and the assembly of several associated epitopes can be used in the treatment of disease. Epitopes can be divided into B cell epitopes and T cell epitopes; B cell epitopes stimulate the body to produce antibodies and are therefore commonly used as targets for the design of serological diagnostic experiments. Meanwhile, epitopes can fall into two possible categories: linear and conformational. This article reviews the role of B cell epitopes in the clinical diagnosis of infectious diseases."], "score": 0.0}, {"id": "(Goulart et al., 2014)", "paper": {"corpus_id": 14872120, "title": "Frontiers of biology in human diseases: strategies for biomolecule's discovery, nanobiotechnologies and biophotonics", "year": 2014, "venue": "BMC Proceedings", "authors": [{"name": "L. Goulart", "authorId": "4233529"}, {"name": "N. Dantas", "authorId": "143629113"}, {"name": "Anielle C. A. Silva", "authorId": "2116671142"}, {"name": "J. M. Madurro", "authorId": "2383336"}, {"name": "A. G. Brito-Madurro", "authorId": "1401154383"}, {"name": "C. Ueira-Vieira", "authorId": "1401154392"}, {"name": "P. Fujimura", "authorId": "6509174"}, {"name": "Y. Maia", "authorId": "5623783"}, {"name": "Paula S. Santos", "authorId": "2068675184"}, {"name": "A. P. Freschi", "authorId": "5688356"}, {"name": "J. Almeida", "authorId": "50310463"}, {"name": "I. Goulart", "authorId": "144926448"}], "n_citations": 3}, "snippets": ["Peptide ligands may be used to map immunologically active sites in proteins, carbohydrates, lipids, and also as individual epitope-mimicking antigens and immunogens (Gazarian et al., 2003)(Gevorkian et al., 2005). The selected mimotopes may also be directly used in phage-based ELISA immunoassays, resulting in simple, specific, sensitive, and low-cost immunodiagnostic tests (Goulart et al., 2010). Similarly, the selection of antibodies from combinatorial libraries has also become an important tool for the generation of reagents, diagnostics, and therapeutic molecules. It is the only method to obtain specific antibodies bypassing the immunization step, which mimics the maturation process of human antibody in vivo, resulting in high affinity antibody ligands, which may be suitable to human administration and potentially applicable to clinical diagnosis and treatment."], "score": 0.91552734375}, {"id": "(Gazarian et al., 2003)", "paper": {"corpus_id": 25709339, "title": "Potential of peptides selected from random phage-displayed libraries to mimic conformational epitopes: a study on scorpion toxin Cn2 and the neutralizing monoclonal antibody BCF2.", "year": 2003, "venue": "Combinatorial chemistry & high throughput screening", "authors": [{"name": "T. Gazarian", "authorId": "6140074"}, {"name": "B. Selisko", "authorId": "50388277"}, {"name": "G. Gurrola", "authorId": "4873827"}, {"name": "R. Hern\u00e1ndez", "authorId": "2068118094"}, {"name": "L. Possani", "authorId": "6089764"}, {"name": "K. Gazarian", "authorId": "5374574"}], "n_citations": 20}, "snippets": ["Many conformational epitopes cannot be mapped by the use of a phage display approach due to the lack of amino acid similarity with the selected peptides. Exploring the potential of the method, we selected mimotopes of the discontinuous, highly conformational epitope of scorpion neurotoxin Cn2, whose 3D structure is known, using its generic neutralizing monoclonal antibody BCF2. With an exhaustive selection procedure, we isolated from a 12-mer phage library a large collection of mimotopes that reproduce the antigenic and immunogenic specificity of the Cn2-epitope. The selected peptides presented three sequence motifs, the most abundant of which, RD(N)XXGF, appeared in 15 different sequence contexts displayed by 97 out of 206 clones. In the most reactive mimotope, displayed by 24 (25%) clones, the motif was flanked by two Cys residues allowing the adoption of a cyclic conformation. Motifs QL(H,M)L(M) and (S/T)WHLP were selected with less efficiency. Comparison of the motifs with the primary and three-dimensional structure of Cn2 as well as with a model of the Cn2-BCF2(Fv) complex suggests that RD(N)XXGF, which does not share sequence similarity with the epitope, mimics its central structural element, turn 7-11, by using an alternative amino acid combination nevertheless keeping the nature of its interactions with BCF2. The QL(H,M)L(M) is assumed to mimic the hydrophobic part of the epitope. The principles of the conformational mimicry by phage-displayed peptides are discussed."], "score": 0.0}, {"id": "(Gevorkian et al., 2005)", "paper": {"corpus_id": 25375064, "title": "Peptide mimotopes of Mycobacterium tuberculosis carbohydrate immunodeterminants.", "year": 2005, "venue": "Biochemical Journal", "authors": [{"name": "G. Gevorkian", "authorId": "5614948"}, {"name": "E. Segura", "authorId": "50780409"}, {"name": "G. Acero", "authorId": "5576198"}, {"name": "J. P. Palma", "authorId": "38551103"}, {"name": "C. Espitia", "authorId": "145464765"}, {"name": "K. Manoutcharian", "authorId": "6894204"}, {"name": "L. L\u00f3pez-Mar\u00edn", "authorId": "1402411438"}], "n_citations": 35}, "snippets": ["Cell-surface saccharides of Mycobacterium tuberculosis appear to be crucial factors in tuberculosis pathogenicity and could be useful antigens in tuberculosis immunodiagnosis. In the present study, we report the successful antigenic and immunogenic mimicry of mannose-containing cell-wall compounds of M. tuberculosis by dodecamer peptides identified by phage-display technology. Using a rabbit antiserum raised against M. tuberculosis cell-surface saccharides as a target for biopanning, peptides with three different consensus sequences were identified. Phage-displayed and chemically synthesized peptides bound to the anticarbohydrate antiserum. Rabbit antibodies elicited against the peptide QEPLMGTVPIRAGGGS recognize the mannosylated M. tuberculosis cell-wall antigens arabinomannan and lipoarabinomannan, and the glycosylated recombinant protein alanine/proline-rich antigen. Furthermore, antibodies were also able to react with mannan from Saccharomyces cerevisiae, but not with phosphatidylinositol dimannosides or arabinogalactan from mycobacteria. These results suggest that the immunogenic peptide mimics oligomannosidic epitopes. Interestingly, this report provides evidence that, in contrast with previously known carbohydrate mimotopes, no aromatic residues are necessary in a peptide sequence for mimicking unusual glycoconjugates synthesized by mycobacteria. The possible usefulness of the identified peptide mimotopes as surrogate reagents for immunodiagnosis and for the study of functional roles of the native non-peptide epitopes is discussed."], "score": 0.0}, {"id": "(Silva et al., 2020)", "paper": {"corpus_id": 225635372, "title": "Phage Display as a Strategy to Obtain Anti-flavivirus Monoclonal Antibodies", "year": 2020, "venue": "Dengue Fever in a One Health Perspective", "authors": [{"name": "I. B. Silva", "authorId": "31418348"}, {"name": "Renato Kaylan Alves Fran\u00e7a", "authorId": "123522793"}, {"name": "Jacyelly Medeiros Silva", "authorId": "2182023756"}, {"name": "A. Maranh\u00e3o", "authorId": "1993312"}, {"name": "C. Prud\u00eancio", "authorId": "4124403"}], "n_citations": 3}, "snippets": ["Some of the main advantages that make this technology so promising are the possibility to obtain human MAbs without in vivo immunization; the enormous diversity of variant antibodies displayed within a single library; the ability to tailor MAbs with the desired properties by using different strategies such as depletion, guided selection, and biochemical control; and the possibility to be applied against practically any kind of target antigen (Sidhu et al., 2019)."], "score": 0.88623046875}, {"id": "(Zhang et al., 2024)", "paper": {"corpus_id": 268017705, "title": "Monoclonal Antibody Development for Cancer Treatment Using the Phage Display Library Platform", "year": 2024, "venue": "Biologics", "authors": [{"name": "Tiantian Zhang", "authorId": "2146334211"}, {"name": "Zhe Wang", "authorId": "2287087475"}], "n_citations": 1}, "snippets": ["This enables the identification of antibodies with superior binding properties compared to those obtained through traditional hybridoma-based methods (Moraes et al., 2021). Additionally, phage display offers greater versatility in antibody engineering, allowing for the incorporation of specific modifications, such as humanization or affinity maturation, to improve therapeutic efficacy and reduce immunogenicity. Moreover, phage display-derived antibodies offer potential benefits in terms of manufacturing scalability and cost effectiveness. Unlike traditional mAbs produced from hybridoma cell lines, phage-derived antibodies can be generated entirely in vitro, eliminating the need for animal immunization and cell culture-based production systems. This streamlined production process enables rapid and cost-effective antibody development, making phage display an attractive platform for the generation of therapeutic antibodies [22]."], "score": 0.9326171875}, {"id": "(Goulart et al., 2010)", "paper": {"corpus_id": 35498330, "title": "Biomarkers for serum diagnosis of infectious diseases and their potential application in novel sensor platforms.", "year": 2010, "venue": "Critical Reviews in Immunology", "authors": [{"name": "L. Goulart", "authorId": "4233529"}, {"name": "C. Vieira", "authorId": "8196251"}, {"name": "A. P. Freschi", "authorId": "5688356"}, {"name": "F. E. Capparelli", "authorId": "84090669"}, {"name": "P. Fujimura", "authorId": "6509174"}, {"name": "J. Almeida", "authorId": "50310463"}, {"name": "L. F. Ferreira", "authorId": "1790496"}, {"name": "I. Goulart", "authorId": "144926448"}, {"name": "A. G. Brito-Madurro", "authorId": "1401154383"}, {"name": "J. M. Madurro", "authorId": "2383336"}], "n_citations": 45}, "snippets": ["Nanotechnological tools and biomarkers for diagnosis and prognosis, as well as strategies for disease control and monitoring populations at higher risk, are continuous worldwide challenges for infectious diseases. Phage display and monoclonal antibody combinatorial libraries are important sources for biomarker discovery and for improved diagnostic strategies. Mimetic peptides were selected against polyclonal antibodies from patients with dengue fever, leprosy, and leishmaniasis as model diseases, and from immunized chickens with total antigens from all three pathogens. Selected single or combined multi-epitope peptide biomarkers were further associated with four different sensor platforms, classified as affinity biosensors, that may be suitable as general protocols for field diagnosis. We have also developed two methods for nanoparticle agglutination assays (a particle gel agglutination test and a magnetic microparticle [MMP]-enzyme-linked immunosorbent assay [ELISA]) and two electrochemical biosensors (impedimetric and amperometric) for DNA and antibody detection. For the agglutination tests, micro- and nanoparticles were coupled with filamentous bacteriophages displaying the selected mimotopes on their surfaces, which has favored the formation of the antigen-antibody or peptide-protein complexes, amplifying the optical detection in ELISA assays or after the chromatographic separation of the microagglutinates. We have also demonstrated a proof-of-concept for the electrochemical biosensors by using electrodes modified with novel functionalized polymers. These electrochemical biosensors have proven to be fast, very sensitive, and specific for the detection of pathogen DNA and circulating antibodies of patients, which may become important in a wide range of diagnostic devices for many infectious agents."], "score": 0.0}], "table": null}, {"title": "Ethical and Practical Considerations", "tldr": "Phage display technology addresses ethical concerns by reducing animal use in antibody production while offering practical advantages for obtaining antibodies against targets where immunization is problematic. This approach aligns with regulatory directives on animal welfare and provides ethically sourced alternatives for diagnostic applications. (5 sources)", "text": "\nPhage display technology offers significant ethical advantages by reducing reliance on animal-derived antibodies, directly supporting EU Directive 2010/63/EU which aims to reduce, refine, and replace animal use in scientific research <Paper corpusId=\"10496834\" paperTitle=\"(McIvor et al., 2013)\" isShortName></Paper>. This ethical benefit is particularly important given that traditional antibody development using animals is not only challenging but also raises animal welfare concerns that many regulatory frameworks now seek to address <Paper corpusId=\"10496834\" paperTitle=\"(McIvor et al., 2013)\" isShortName></Paper> <Paper corpusId=\"9420027\" paperTitle=\"(Smith, 1985)\" isShortName></Paper>.\n\nA key practical advantage of phage display is its versatility in antibody sourcing. The technology allows for generating antibodies from diverse species including humans, camels, llamas, alpacas, chimpanzees, macaques, pigs, mice, chickens, and sharks <Paper corpusId=\"235748443\" paperTitle=\"(Roth et al., 2021)\" isShortName></Paper>. This flexibility is particularly valuable when working with immune libraries from convalescent patients or immunized donors, enabling researchers to isolate affinity-matured antibodies directly <Paper corpusId=\"235748443\" paperTitle=\"(Roth et al., 2021)\" isShortName></Paper>.\n\nPerhaps most importantly, phage display provides practical solutions in scenarios where immunization is impossible, ethically problematic, or when patient samples are unavailable <Paper corpusId=\"31871816\" paperTitle=\"(Kuhn et al., 2016)\" isShortName></Paper>. The technology's in vitro nature circumvents immune system limitations, theoretically allowing antibody generation against virtually any conceivable molecule <Paper corpusId=\"31871816\" paperTitle=\"(Kuhn et al., 2016)\" isShortName></Paper>. For instance, universal antibody gene libraries offer alternatives when traditional immunization approaches are not feasible <Paper corpusId=\"235748443\" paperTitle=\"(Roth et al., 2021)\" isShortName></Paper>.\n\nIn practical applications, engineered bacteriophages demonstrate exceptional potential for ethical detection methods. For example, bacteriophages displaying specific antibody fragments or mimotopes have shown high affinity for targets like cholera toxin, offering precise quantification capabilities without relying on animal-derived methods <Paper corpusId=\"261854381\" paperTitle=\"(Li et al., 2023)\" isShortName></Paper>. This approach represents an important shift toward more ethical detection strategies while maintaining or even improving sensitivity and accuracy <Paper corpusId=\"261854381\" paperTitle=\"(Li et al., 2023)\" isShortName></Paper>.\n\nThe ability to easily engineer phage-displayed antibodies according to application requirements provides additional practical benefits <Paper corpusId=\"31871816\" paperTitle=\"(Kuhn et al., 2016)\" isShortName></Paper>. Since the DNA sequence encoding the antibodies is directly accessible from the phage, researchers can modify antibodies to suit specific diagnostic contexts, adding another layer of practical advantage to this ethically sound technology <Paper corpusId=\"31871816\" paperTitle=\"(Kuhn et al., 2016)\" isShortName></Paper>.", "citations": [{"id": "(McIvor et al., 2013)", "paper": {"corpus_id": 10496834, "title": "Phage Display-Derived Binders Able to Distinguish Listeria monocytogenes from Other Listeria Species", "year": 2013, "venue": "PLoS ONE", "authors": [{"name": "M. J. McIvor", "authorId": "2124972713"}, {"name": "N. Karoonuthaisiri", "authorId": "6141448"}, {"name": "Ratthaphol Charlermroj", "authorId": "3555986"}, {"name": "L. Stewart", "authorId": "153497667"}, {"name": "C. Elliott", "authorId": "145480579"}, {"name": "I. Grant", "authorId": "4318116"}], "n_citations": 22}, "snippets": ["Development of animal derived antibodies is not an easy task and they are expensive to produce. In addition efforts are ongoing to reduce, refine and replace the use of animals in scientific research in accordance with EU legislation, Directive 2010/63/EU [21]. Phage display biopanning is a technique extending from the invention of phage display technology in 1985 (Smith, 1985) and offers an alternative means of generating specific affinity ligands."], "score": 0.91455078125}, {"id": "(Smith, 1985)", "paper": {"corpus_id": 9420027, "title": "Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.", "year": 1985, "venue": "Science", "authors": [{"name": "G. P. Smith", "authorId": "2254711382"}], "n_citations": 3900}, "snippets": ["Foreign DNA fragments can be inserted into filamentous phage gene III to create a fusion protein with the foreign sequence in the middle. The fusion protein is incorporated into the virion, which retains infectivity and displays the foreign amino acids in immunologically accessible form. These \"fusion phage\" can be enriched more than 1000-fold over ordinary phage by affinity for antibody directed against the foreign sequence. Fusion phage may provide a simple way of cloning a gene when an antibody against the product of that gene is available."], "score": 0.0}, {"id": "(Roth et al., 2021)", "paper": {"corpus_id": 235748443, "title": "Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy", "year": 2021, "venue": "Frontiers in Cellular and Infection Microbiology", "authors": [{"name": "K. D. R. Roth", "authorId": "48052198"}, {"name": "E. Wenzel", "authorId": "28357282"}, {"name": "Maximilian Ruschig", "authorId": "46227616"}, {"name": "S. Steinke", "authorId": "7955506"}, {"name": "Nora Langreder", "authorId": "1744688267"}, {"name": "P. A. Heine", "authorId": "52166487"}, {"name": "Kai-Thomas Schneider", "authorId": "1742547800"}, {"name": "Rico Ballmann", "authorId": "1743475436"}, {"name": "Viola F\u00fchner", "authorId": "6680500"}, {"name": "P. Kuhn", "authorId": "153674227"}, {"name": "T. Schirrmann", "authorId": "6511832"}, {"name": "A. Frenzel", "authorId": "3909598"}, {"name": "S. D\u00fcbel", "authorId": "4494940"}, {"name": "M. Schubert", "authorId": "145165369"}, {"name": "G. Moreira", "authorId": "2441364"}, {"name": "F. Bertoglio", "authorId": "3682127"}, {"name": "Giulio Russo", "authorId": "49440587"}, {"name": "M. Hust", "authorId": "6956173"}], "n_citations": 53}, "snippets": ["Antibody phage display allows the generation of antibodies originating from several species, including human, camel, llama, alpaca, chimpanzee, macaque, pig, mice, chicken or shark. These antibodies are derived from two types of library  sources: immune or universal libraries. Immune libraries are preferred when convalescent patients or immunized animals/ human donors are available. This approach offers the advantage to directly isolate affinity matured antibodies. Universal antibody gene libraries offer an alternative if immunization is not possible, ethically not feasible or patient samples are not available."], "score": 0.9345703125}, {"id": "(Kuhn et al., 2016)", "paper": {"corpus_id": 31871816, "title": "Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display", "year": 2016, "venue": "PROTEOMICS - Clinical Applications", "authors": [{"name": "P. Kuhn", "authorId": "153674227"}, {"name": "Viola F\u00fchner", "authorId": "6680500"}, {"name": "Tobias Unkauf", "authorId": "13828519"}, {"name": "G. Moreira", "authorId": "2441364"}, {"name": "A. Frenzel", "authorId": "3909598"}, {"name": "Sebastian Miethe", "authorId": "5472382"}, {"name": "M. Hust", "authorId": "6956173"}], "n_citations": 65}, "snippets": ["This in vitro technology circumvents the limitations of the immune system and allows\u2014in theory\u2014the generation of antibodies against all conceivable molecules. Phage display technology enables obtaining human antibodies from na\u00efve antibody gene libraries when either patients are not available or immunization is not ethically feasible. On the other hand, if patients or immunized/infected animals are available, it is common to construct immune phage display libraries to select in vivo affinity\u2010matured antibodies. Because the phage packaged DNA sequence encoding the antibodies is directly available, the antibodies can be smoothly engineered according to the requirements of the final application."], "score": 0.947265625}, {"id": "(Li et al., 2023)", "paper": {"corpus_id": 261854381, "title": "Advances in phage display based nano immunosensors for cholera toxin", "year": 2023, "venue": "Frontiers in Immunology", "authors": [{"name": "Yang Li", "authorId": "2167582039"}, {"name": "Kai-di Yang", "authorId": "2241111336"}, {"name": "De-cai Kong", "authorId": "2240930501"}, {"name": "Jun-feng Ye", "authorId": "29557361"}], "n_citations": 5}, "snippets": ["Engineered bacteriophages exhibit exceptional cholera toxin affinity, through specific antibody fragments or mimotopes, enabling precise quantification. This innovative approach promises to reshape cholera toxin detection, offering an alternative to animal-derived methods. Harnessing engineered bacteriophages aligns with ethical detection and emphasizes sensitivity and accuracy, a pivotal stride in the evolution of detection strategies."], "score": 0.9580078125}], "table": null}, {"title": "Diagnostic Applications and Performance", "tldr": "Phage display-derived antibodies have demonstrated superior performance in multiple diagnostic platforms including lateral flow assays, ELISA, and SPR-based biosensors, offering faster results and greater sensitivity than traditional methods. These antibodies can detect diverse pathogens with high specificity, requiring minimal sample preparation and providing results in minutes rather than hours or days needed for conventional testing. (10 sources)", "text": "\nPhage display technology has enabled the development of antibody-based diagnostics with exceptional versatility across different detection platforms. These antibodies can be readily incorporated into conventional enzyme-linked immunosorbent assays (ELISA) as well as cutting-edge biotechnological platforms like surface plasmon resonance (SPR) immunosensors <Paper corpusId=\"212737645\" paperTitle=\"(Lima et al., 2020)\" isShortName></Paper> <Paper corpusId=\"25303200\" paperTitle=\"(Rojas et al., 2014)\" isShortName></Paper>. This adaptability makes phage-derived antibodies particularly valuable for a wide range of diagnostic applications.\n\nA major performance advantage of phage display antibodies is their remarkable detection speed. For instance, lateral flow test strips employing phage-displayed antibody fragments can detect live Salmonella within just 15 minutes, while conventional biochemical and serological confirmation tests require at least 24 hours <Paper corpusId=\"252570448\" paperTitle=\"(Charlermroj et al., 2022)\" isShortName></Paper>. This dramatic reduction in detection time allows for more rapid clinical decision-making and infection control measures.\n\nPhage display-derived antibodies also demonstrate impressive sensitivity in diagnostic applications. Research has shown that phage-mediated ELISA can be more sensitive toward antigens compared to conventional antibody-based ELISA methods <Paper corpusId=\"270748518\" paperTitle=\"(Sadraeian et al., 2024)\" isShortName></Paper>. This enhanced sensitivity is exemplified in a phage-ELISA system for Salmonella enteritidis detection that achieved a detection limit of 10\u2074 CFU/mL, surpassing traditional ELISA sensitivity by an order of magnitude <Paper corpusId=\"275409337\" paperTitle=\"(Shen et al., 2025)\" isShortName></Paper>. This improved performance can be attributed to the capacity for multiple antibody probes to simultaneously bind to a single target and each phage clone's ability to accommodate hundreds of reporter-labeled antibodies.\n\nThe technology has proven particularly valuable for developing diagnostic tools for dangerous pathogens. Phage display has been utilized to create new diagnostic tools for lethal viruses including Zika, Ebola, Hendra, Nipah, Hanta, Middle East respiratory disease (MERS), and SARS <Paper corpusId=\"259226246\" paperTitle=\"(Guliy et al._1, 2023)\" isShortName></Paper> <Paper corpusId=\"232158116\" paperTitle=\"(Anand et al., 2021)\" isShortName></Paper> <Paper corpusId=\"31871816\" paperTitle=\"(Kuhn et al., 2016)\" isShortName></Paper>. Although PCR remains the gold standard for viral detection, sensor technologies using phage antibodies as sensitive elements are increasingly promising due to their simplicity, effectiveness, rapid results, and cost-efficiency.\n\nAnother significant diagnostic advantage is the ability to develop antibodies that can distinguish between highly related antigens. Researchers have demonstrated that within just four weeks, phage display can generate panels of IgGs capable of differentiating between influenza virus nucleoprotein (NP) subtypes with sequence identities exceeding 90% <Paper corpusId=\"221018675\" paperTitle=\"(Yu et al., 2020)\" isShortName></Paper>. These antibodies exhibited detection limits below 1 nM for viral NP from lysed virus samples using sandwich ELISA, with affinities comparable to mouse antibodies but obtained in a fraction of the time.\n\nPhage display also offers unique advantages for high-throughput diagnostic applications. The technology allows peptides of various sizes to be easily expressed, with libraries that can be amplified to produce high-titer stock solutions that can be replenished indefinitely. Screening can be conducted in small manageable micro-volumes, making phage-displayed domain scans particularly suitable for high-throughput applications <Paper corpusId=\"231858431\" paperTitle=\"(Hada-Neeman et al., 2021)\" isShortName></Paper>. Additionally, next-generation sequencing multiplexing enables comprehensive analysis of affinity-selected peptides, providing a broader view of humoral immune responses to infections and other conditions.", "citations": [{"id": "(Lima et al., 2020)", "paper": {"corpus_id": 212737645, "title": "Biotechnological and Immunological Platforms Based on PGL-I Carbohydrate-Like Peptide of Mycobacterium leprae for Antibodies Detection Among Leprosy Clinical Forms", "year": 2020, "venue": "Frontiers in Microbiology", "authors": [{"name": "M. Lima", "authorId": "39729432"}, {"name": "F. E. Capparelli", "authorId": "84090669"}, {"name": "Jaqueline das Dores Dias Oliveira", "authorId": "1567333609"}, {"name": "P. Fujimura", "authorId": "6509174"}, {"name": "E. C. Moraes", "authorId": "2121678427"}, {"name": "Ester Cristina Borges Araujo", "authorId": "47282583"}, {"name": "N. M. Silva", "authorId": "5088161"}, {"name": "R. P. Alves-Balvedi", "authorId": "1402708869"}, {"name": "A. G. Brito-Madurro", "authorId": "1401154383"}, {"name": "I. Goulart", "authorId": "144926448"}, {"name": "L. Goulart", "authorId": "4233529"}], "n_citations": 7}, "snippets": ["One of the great advantages of peptides and antibodies obtained by PD is their flexibility to be used in different diagnostic platforms, from conventional enzyme-linked immunosorbent assay (ELISA) (Rojas et al., 2014) to biotechnological platforms, such as those involving immunosensors based on surface plasmon resonance (SPR) (Kim et al., 2014)."], "score": 0.88623046875}, {"id": "(Rojas et al., 2014)", "paper": {"corpus_id": 25303200, "title": "High throughput functional epitope mapping: Revisiting phage display platform to scan target antigen surface", "year": 2014, "venue": "mAbs", "authors": [{"name": "G. Rojas", "authorId": "144739240"}, {"name": "Y. Tundidor", "authorId": "15298285"}, {"name": "Y. Infante", "authorId": "16210048"}], "n_citations": 30}, "snippets": ["Antibody engineering must be accompanied by mapping strategies focused on identifying the epitope recognized by each antibody to define its unique functional identity. High throughput fine specificity determination remains technically challenging. We review recent experiences aimed at revisiting the oldest and most extended display technology to develop a robust epitope mapping platform, based on the ability to manipulate target-derived molecules (ranging from the whole native antigen to antigen domains and smaller fragments) on filamentous phages. Single, multiple and combinatorial mutagenesis allowed comprehensive scanning of phage-displayed antigen surface that resulted in the identification of clusters of residues contributing to epitope formation. Functional pictures of the epitope(s) were thus delineated in the natural context. Successful mapping of antibodies against interleukin-2, epidermal growth factor and its receptor, and vascular endothelial growth factor showed the versatility of these procedures, which combine the accuracy of site-directed mutagenesis with the high throughput potential of phage display."], "score": 0.0}, {"id": "(Charlermroj et al., 2022)", "paper": {"corpus_id": 252570448, "title": "A rapid colorimetric lateral flow test strip for detection of live Salmonella Enteritidis using whole phage as a specific binder", "year": 2022, "venue": "Frontiers in Microbiology", "authors": [{"name": "Ratthaphol Charlermroj", "authorId": "3555986"}, {"name": "Manlika Makornwattana", "authorId": "11397628"}, {"name": "Sudtida Phuengwas", "authorId": "11639620"}, {"name": "N. Karoonuthaisiri", "authorId": "6141448"}], "n_citations": 6}, "snippets": ["Phage display technology is an effective alternative method to obtain antibodies with the desired specificity against selected antigenic molecules", "The selected phage-displayed antibody fragments were subsequently employed to develop a lateral flow test strip assay for the detection of live Salmonella. The test strips showed specificity to Salmonella Enteritidis without cross-reactivity to eight serovars of Salmonella or other bacteria strains. The test strip assay requires 15 min, whereas the conventional biochemical and serological confirmation test requires at least 24 h."], "score": 0.93359375}, {"id": "(Sadraeian et al., 2024)", "paper": {"corpus_id": 270748518, "title": "Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases", "year": 2024, "venue": "Molecules", "authors": [{"name": "Mohammad Sadraeian", "authorId": "9917727"}, {"name": "Reza Maleki", "authorId": "2296344766"}, {"name": "Mahta Moraghebi", "authorId": "1659475048"}, {"name": "Abasalt Bahrami", "authorId": "2262937686"}], "n_citations": 5}, "snippets": ["Since this technology comprises an in vitro screening procedure, it has eliminated the limitations and constraints of hybridoma technology [25]", "Although generating monoclonal antibodies is both an expensive and time-consuming task, they are widely deployed in immunological tests. In contrast, phage display allows for the quick collection of recombinant antibodies at a low cost and with the same affinity. Furthermore, in certain investigations, antibodies generated through phage display were more sensitive toward an antigen compared to other traditional techniques. A peptide that binds the spike protein of the transmissible gastroenteritis virus (TGEV) was developed by Suo and colleagues using phage display for diagnostic purposes. It was discovered that phage-mediated ELISA was more sensitive than conventional antibody-based ELISA [27]."], "score": 0.9150390625}, {"id": "(Shen et al., 2025)", "paper": {"corpus_id": 275409337, "title": "Phage-ELISA for ultrasensitive detection of Salmonella enteritidis.", "year": 2025, "venue": "In Analysis", "authors": [{"name": "Mangmang Shen", "authorId": "2272015775"}, {"name": "Chang Ni", "authorId": "120717344"}, {"name": "Jiasheng Yuan", "authorId": "1567115420"}, {"name": "Xin Zhou", "authorId": "2319314980"}], "n_citations": 0}, "snippets": ["Owing to the capacity of multiple C50041-scFv-4 probes to simultaneously bind to a single target Salmonella and each phage clone's ability to accommodate hundreds of HRP-labeled antibodies, the proposed phage-ELISA demonstrated remarkable sensitivity (104 CFU mL-1) for detecting Salmonella enteritidis samples. This sensitivity surpasses that of traditional ELISA by one order of magnitude in this study."], "score": 0.904296875}, {"id": "(Guliy et al._1, 2023)", "paper": {"corpus_id": 259226246, "title": "Antibody Phage Display Technology for Sensor-Based Virus Detection: Current Status and Future Prospects", "year": 2023, "venue": "Biosensors", "authors": [{"name": "O. Guliy", "authorId": "2290767890"}, {"name": "S. Evstigneeva", "authorId": "7399912"}, {"name": "V. Khanadeev", "authorId": "3719520"}, {"name": "L. Dykman", "authorId": "34641005"}], "n_citations": 7}, "snippets": ["Phage display technology antibodies as nano-bio-engineered macromolecules can be used for sensor-based virus detection. In order to recognize lethal viruses such as Zika, Ebola, Hendra, Nipah, Hanta, Middle East respiratory disease (MERS), and SARS, phage display has been utilized to create new diagnostic tools (Kuhn et al., 2016)(Anand et al., 2021)", "The selection of antibody fragments from phage display libraries thus offers the potential to access very large numbers of molecules with different binding specificities quickly and cheaply, avoiding the need for animal immunizations. The scFv can be genetically engineered to produce tailored constructs as described above. Such phage antibodies can be coated directly onto metal, plastic, silica or carbon surfaces by simple adsorption, which, as discussed above, is adequate for biosensor-based assays", "Despite its drawbacks, the use of PCR to identify particular viral genomic sequences while an infection is still active is still regarded as the best virus detection technique. However, sensor technologies using phage antibodies as sensitive elements are very promising because antibodies generated by phage display are an excellent alternative to classical antibodies", "Phage display is a powerful tool for target ligand selection owing to its being simple, highly effective, rapid, and cheap."], "score": 0.93408203125}, {"id": "(Anand et al., 2021)", "paper": {"corpus_id": 232158116, "title": "Phage Display Technique as a Tool for Diagnosis and Antibody Selection for Coronaviruses", "year": 2021, "venue": "Current Microbiology", "authors": [{"name": "T. Anand", "authorId": "145780422"}, {"name": "N. Virmani", "authorId": "5330684"}, {"name": "B. C. Bera", "authorId": "48377477"}, {"name": "R. Vaid", "authorId": "32133171"}, {"name": "M. Vashisth", "authorId": "28295056"}, {"name": "Priyanka Bardajatya", "authorId": "2052184685"}, {"name": "Ashok Kumar", "authorId": "2118070220"}, {"name": "B. N. Tripathi", "authorId": "38216015"}], "n_citations": 48}, "snippets": ["Major advantages of antibody phage display include as follows: production of large-sized combinatorial libraries, improved efficiency than conventional hybridoma system, easy manipulation, safety, no involvement of animal cell culture, lower propagative cost and easy screening procedures involved to select target specific binders (Bazan et al., 2012)(Pande et al., 2010)(Ledsgaard et al., 2018). Specifically for viral pathogens, antibody phage display is an alternative tool to hybridoma technology, since it circumvents the limitations of the immune system (Aghebati-Maleki et al., 2016)."], "score": 0.931640625}, {"id": "(Kuhn et al., 2016)", "paper": {"corpus_id": 31871816, "title": "Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display", "year": 2016, "venue": "PROTEOMICS - Clinical Applications", "authors": [{"name": "P. Kuhn", "authorId": "153674227"}, {"name": "Viola F\u00fchner", "authorId": "6680500"}, {"name": "Tobias Unkauf", "authorId": "13828519"}, {"name": "G. Moreira", "authorId": "2441364"}, {"name": "A. Frenzel", "authorId": "3909598"}, {"name": "Sebastian Miethe", "authorId": "5472382"}, {"name": "M. Hust", "authorId": "6956173"}], "n_citations": 65}, "snippets": ["This in vitro technology circumvents the limitations of the immune system and allows\u2014in theory\u2014the generation of antibodies against all conceivable molecules. Phage display technology enables obtaining human antibodies from na\u00efve antibody gene libraries when either patients are not available or immunization is not ethically feasible. On the other hand, if patients or immunized/infected animals are available, it is common to construct immune phage display libraries to select in vivo affinity\u2010matured antibodies. Because the phage packaged DNA sequence encoding the antibodies is directly available, the antibodies can be smoothly engineered according to the requirements of the final application."], "score": 0.947265625}, {"id": "(Yu et al., 2020)", "paper": {"corpus_id": 221018675, "title": "A panel of anti-influenza virus nucleoprotein antibodies selected from phage-displayed synthetic antibody libraries with rapid diagnostic capability to distinguish diverse influenza virus subtypes", "year": 2020, "venue": "Scientific Reports", "authors": [{"name": "Chung-Ming Yu", "authorId": "80087979"}, {"name": "I. Chen", "authorId": "6140714"}, {"name": "Chao-Ping Tung", "authorId": "49041027"}, {"name": "Hung-Pin Peng", "authorId": "39793613"}, {"name": "J. Jian", "authorId": "6612770"}, {"name": "Yi-Kai Chiu", "authorId": "10142191"}, {"name": "Yueh-Liang Tsou", "authorId": "4496798"}, {"name": "Hong-Sen Chen", "authorId": "2144190869"}, {"name": "Yi-Jen Huang", "authorId": "2108597209"}, {"name": "W. Hsiao", "authorId": "2068785808"}, {"name": "Y. Wang", "authorId": "2153952070"}, {"name": "A. Yang", "authorId": "39833286"}], "n_citations": 8}, "snippets": ["The downsides of the animal-based antibodies as affinity reagents arise from the requirement of months of development timespan and limited choices of antibody candidates due to immunodominance of humoral immune responses in animals. Hence, developing animal antibodies capable of distinguishing highly related antigens could be challenging. To overcome the limitation imposed by the animal immune systems, we developed an in vitro methodology based on phage-displayed synthetic antibody libraries for diverse antibodies as affinity reagents against closely related influenza virus nucleoprotein (NP) subtypes", "We applied the methodology to attain, within four weeks, a panel of IgGs with distinguishable specificities against a group of representative NPs with pairwise amino acid sequence identities up to more than 90%, and the antibodies derived from the antibody libraries without further affinity refinement had comparable affinity of mouse antibodies to the NPs with the detection limit less than 1 nM of viral NP from lysed virus with sandwich ELISA."], "score": 0.9248046875}, {"id": "(Hada-Neeman et al., 2021)", "paper": {"corpus_id": 231858431, "title": "Domain-Scan: Combinatorial Sero-Diagnosis of Infectious Diseases Using Machine Learning", "year": 2021, "venue": "Frontiers in Immunology", "authors": [{"name": "Smadar Hada-Neeman", "authorId": "1992965302"}, {"name": "Yael Weiss-Ottolenghi", "authorId": "1403911013"}, {"name": "Naama Wagner", "authorId": "153211473"}, {"name": "Oren Avram", "authorId": "6922959"}, {"name": "Haim Ashkenazy", "authorId": "2428327"}, {"name": "Y. Maor", "authorId": "34769728"}, {"name": "E. Sklan", "authorId": "5292106"}, {"name": "D. Shcherbakov", "authorId": "2082248830"}, {"name": "T. Pupko", "authorId": "1963380"}, {"name": "J. Gershoni", "authorId": "1922569"}], "n_citations": 8}, "snippets": ["The use of phage-display, as a means to present peptides for antibody interrogation, offers a number of advantages: (1) Peptides ranging from tens to hundreds of amino acids can easily be expressed; (2) Once cloned, the peptide library can be amplified to produce high titer-stock solutions that can be replenished endlessly; (3) The screening of phage-display peptide arrays can be conducted in small manageable micro-volumes, making phage-displayed Domain-Scans particularly amenable to high-throughput applications, screening numerous samples easily; (4) NGS multiplexing allows the analysis of the affinity-selected peptides, generating mega-data portraying a broader and more comprehensive view of the humoral immune response to infection and other morbidities."], "score": 0.90869140625}], "table": null}, {"title": "Economic Advantages", "tldr": "Phage display technology significantly reduces antibody production costs by eliminating expensive hybridoma cell culture facilities and using bacterial expression systems instead. The economic benefits extend to faster development timelines, simplified production processes, and built-in signal amplification properties that eliminate the need for additional detection reagents. (10 sources)", "text": "\nPhage display technology offers substantial economic advantages over traditional antibody production methods. Perhaps most significantly, the technology dramatically reduces production costs by enabling antibody propagation in simple bacterial systems like E. coli rather than requiring specialized and expensive hybridoma cell culture facilities <Paper corpusId=\"198254683\" paperTitle=\"(Peltomaa et al., 2019)\" isShortName></Paper> <Paper corpusId=\"11867879\" paperTitle=\"(Byrne et al., 2009)\" isShortName></Paper>. This alternative production platform represents a major cost-saving advantage for diagnostic applications.\n\nThe economic benefits of phage display extend beyond just production systems. The technology allows for the rapid development of antibodies with high binding affinity and selectivity at \"a fraction of the conventional cost\" <Paper corpusId=\"55838761\" paperTitle=\"(Ch'ng et al., 2016)\" isShortName></Paper>. Traditional monoclonal antibody production is widely recognized as both expensive and time-consuming, while phage display enables quick collection of recombinant antibodies with comparable affinity at significantly lower costs <Paper corpusId=\"270748518\" paperTitle=\"(Sadraeian et al., 2024)\" isShortName></Paper> <Paper corpusId=\"14579386\" paperTitle=\"(Ferrara et al., 2012)\" isShortName></Paper>.\n\nPhage-like antibodies offer additional economic advantages through their intrinsic properties, including low production costs combined with low molecular weight and high stability <Paper corpusId=\"265444141\" paperTitle=\"(Guliy et al., 2023)\" isShortName></Paper>. These characteristics make them particularly cost-effective for biosensor applications. Studies have confirmed that phage antibodies not only ensure highly sensitive antigen detection but are also \"much cheaper to make\" than traditional antibody alternatives <Paper corpusId=\"271163341\" paperTitle=\"(Guliy et al., 2024)\" isShortName></Paper>.\n\nAnother economic benefit comes from the built-in signal amplification capabilities of phage-displayed antibodies. M13 filamentous phages contain approximately 2,700 copies of the major pVIII coat protein per particle, which can be leveraged for significant signal enhancement using reporter-conjugated anti-M13 antibodies <Paper corpusId=\"201228624\" paperTitle=\"(Qiu et al., 2019)\" isShortName></Paper>. This natural amplification system can reduce or eliminate the need for additional costly detection reagents in diagnostic applications.\n\nThe overall economic value proposition of landscape phage-based interfaces is compelling. These systems have performed \"much more effectively than their natural immunoglobulin counterparts\" in various detector platforms while addressing the limitations of traditional monoclonal antibodies, which include \"high cost, low specificity, less-than-optimal affinity, and sensitivity to environmental stresses\" <Paper corpusId=\"46974853\" paperTitle=\"(Petrenko, 2018)\" isShortName></Paper> <Paper corpusId=\"9192594\" paperTitle=\"(Petrenko et al., 2000)\" isShortName></Paper>. By providing a more cost-effective alternative that maintains or improves performance, phage display technology offers significant economic advantages for pathogen detection diagnostics.", "citations": [{"id": "(Peltomaa et al., 2019)", "paper": {"corpus_id": 198254683, "title": "Phage Display in the Quest for New Selective Recognition Elements for Biosensors", "year": 2019, "venue": "ACS Omega", "authors": [{"name": "Riikka Peltomaa", "authorId": "3554578"}, {"name": "E. Benito-Pe\u00f1a", "authorId": "1401480712"}, {"name": "R. Barderas", "authorId": "5941973"}, {"name": "M. Moreno-Bondi", "authorId": "1398106433"}], "n_citations": 73}, "snippets": ["Moreover, unlike full-length antibodies, recombinant antibody fragments can be propagated in bacteria, such as E. coli, which significantly lower the cost of production as no specialized cell culture facilities for hybridoma cell lines are needed. (Byrne et al., 2009)(Charlton, 2004) On the other hand, phage display also offers the possibility of selecting various other bioinspired recognition elements, (Peltomaa et al., 2017) such as peptides or other binding proteins and scaffolds, which might provide further advantages compared to antibodies. In vitro selections by phage display facilitates the production of novel receptors beyond known biomolecular interactions, or against toxic or nonimmunogenic targets, or even using whole cells as the target. 1"], "score": 0.927734375}, {"id": "(Byrne et al., 2009)", "paper": {"corpus_id": 11867879, "title": "Antibody-Based Sensors: Principles, Problems and Potential for Detection of Pathogens and Associated Toxins", "year": 2009, "venue": "Italian National Conference on Sensors", "authors": [{"name": "B. Byrne", "authorId": "145734208"}, {"name": "E. Stack", "authorId": "35157782"}, {"name": "N. Gilmartin", "authorId": "6889038"}, {"name": "R. O\u2019Kennedy", "authorId": "11755579"}], "n_citations": 346}, "snippets": ["Antibody-based sensors permit the rapid and sensitive analysis of a range of pathogens and associated toxins. A critical assessment of the implementation of such formats is provided, with reference to their principles, problems and potential for \u2018on-site\u2019 analysis. Particular emphasis is placed on the detection of foodborne bacterial pathogens, such as Escherichia coli and Listeria monocytogenes, and additional examples relating to the monitoring of fungal pathogens, viruses, mycotoxins, marine toxins and parasites are also provided."], "score": 0.0}, {"id": "(Ch'ng et al., 2016)", "paper": {"corpus_id": 55838761, "title": "Phage Display\u2010Derived Antibodies: Application of Recombinant Antibodies for Diagnostics", "year": 2016, "venue": "", "authors": [{"name": "Angela Chiew Wen Ch\u2019ng", "authorId": "1412157815"}, {"name": "Y. Choong", "authorId": "2158170"}, {"name": "T. S. Lim", "authorId": "1734088"}], "n_citations": 12}, "snippets": ["The ability to produce antibodies via recombinant methods can help to improve the speed at which newer antibodies are produced at a fraction of the conventional cost. The freedom associated with recombinant antibodies would also allow the customization of antibodies for various downstream applications in diagnostics. This is particularly important as the development of newer technologies in sensing and reporting mechanisms, the flexibility of recombinant antibodies towards modifications would allow the antibodies to evolve with the advancement of sensing technologies."], "score": 0.94091796875}, {"id": "(Sadraeian et al., 2024)", "paper": {"corpus_id": 270748518, "title": "Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases", "year": 2024, "venue": "Molecules", "authors": [{"name": "Mohammad Sadraeian", "authorId": "9917727"}, {"name": "Reza Maleki", "authorId": "2296344766"}, {"name": "Mahta Moraghebi", "authorId": "1659475048"}, {"name": "Abasalt Bahrami", "authorId": "2262937686"}], "n_citations": 5}, "snippets": ["Since this technology comprises an in vitro screening procedure, it has eliminated the limitations and constraints of hybridoma technology [25]", "Although generating monoclonal antibodies is both an expensive and time-consuming task, they are widely deployed in immunological tests. In contrast, phage display allows for the quick collection of recombinant antibodies at a low cost and with the same affinity. Furthermore, in certain investigations, antibodies generated through phage display were more sensitive toward an antigen compared to other traditional techniques. A peptide that binds the spike protein of the transmissible gastroenteritis virus (TGEV) was developed by Suo and colleagues using phage display for diagnostic purposes. It was discovered that phage-mediated ELISA was more sensitive than conventional antibody-based ELISA [27]."], "score": 0.9150390625}, {"id": "(Ferrara et al., 2012)", "paper": {"corpus_id": 14579386, "title": "Using Phage and Yeast Display to Select Hundreds of Monoclonal Antibodies: Application to Antigen 85, a Tuberculosis Biomarker", "year": 2012, "venue": "PLoS ONE", "authors": [{"name": "F. Ferrara", "authorId": "46773024"}, {"name": "L. Naranjo", "authorId": "4899598"}, {"name": "Sandeep Kumar", "authorId": "2109726524"}, {"name": "T. Gaiotto", "authorId": "5348591"}, {"name": "H. Mukundan", "authorId": "2215428"}, {"name": "B. Swanson", "authorId": "47630416"}, {"name": "A. Bradbury", "authorId": "145028383"}], "n_citations": 76}, "snippets": ["The monoclonal antibodies (mAbs) identified in this way show high binding affinity and selectivity for the antigens and offer an advantage over traditional mAbs produced by relatively expensive and time consuming techniques."], "score": 0.9619140625}, {"id": "(Guliy et al., 2023)", "paper": {"corpus_id": 265444141, "title": "Optical Sensors for Bacterial Detection", "year": 2023, "venue": "Italian National Conference on Sensors", "authors": [{"name": "O. Guliy", "authorId": "3738457"}, {"name": "O. Karavaeva", "authorId": "6043533"}, {"name": "Andrey Smirnov", "authorId": "2307813476"}, {"name": "S. A. Eremin", "authorId": "2268221008"}, {"name": "V. Bunin", "authorId": "40456403"}], "n_citations": 17}, "snippets": ["Phage-like antibodies have advantages such as in vitro production, a low cost, a low molecular weight, and high stability (Nanduri et al., 2007). Phage display antibodies have been used to detect Listeria monocytogenes in an SPR biosensor (detection limit, 2 \u00d7 10 6 CFU/mL), which indicates the promise of non-antibody recognition elements (Nanduri et al., 2007)."], "score": 0.8779296875}, {"id": "(Guliy et al., 2024)", "paper": {"corpus_id": 271163341, "title": "Phage Antibodies for Detection of Diagnostically Important Antigens.", "year": 2024, "venue": "Frontiers in Bioscience", "authors": [{"name": "O. Guliy", "authorId": "3738457"}, {"name": "V. A. Khanadeev", "authorId": "2283420197"}, {"name": "L. Dykman", "authorId": "34641005"}], "n_citations": 3}, "snippets": ["Phage Abs are an excellent alternative to mono- and polyclonal Abs, because they are highly stable, have no disulfide bonds, and are much cheaper to make", ".Many studies have confirmed that unlike other types of Abs, phage Abs ensure highly sensitive Ag detection."], "score": 0.94677734375}, {"id": "(Qiu et al., 2019)", "paper": {"corpus_id": 201228624, "title": "Phage-displayed nanobody based double antibody sandwich chemiluminescent immunoassay for the detection of Cry2A toxin in cereals", "year": 2019, "venue": "Food and Agricultural Immunology", "authors": [{"name": "Yulou Qiu", "authorId": "12702841"}, {"name": "Pan Li", "authorId": "1798143258"}, {"name": "Beibei Liu", "authorId": "2108662168"}, {"name": "Yuan Liu", "authorId": "2143860177"}, {"name": "Yulong Wang", "authorId": "2115663670"}, {"name": "Tingting Tao", "authorId": "47361440"}, {"name": "Junli Xu", "authorId": "2150635918"}, {"name": "B. Hammock", "authorId": "3767289"}, {"name": "Xianjin Liu", "authorId": "8016566"}, {"name": "Rongfa Guan", "authorId": "37298327"}, {"name": "Cunzheng Zhang", "authorId": "4684238"}], "n_citations": 14}, "snippets": ["Compared with conventional antibodies, nanobodies have high stability, high affinity, the advantages of easy to produce, and can recognize inaccessible epitopes", "Moreover, phage-displayed nanobodies can provide an advantage over the soluble nanobodies being used as reporter elements for immunoassays development. For example, M13 phage particles contain approximately 2700 copies of pVIII capsid protein per phage. This can be used for signal amplification and modification", "When compared with the traditional antibodies or soluble nanobodies, phage-displayed nanobodies have the advantages of ease of production, reproducibility and lowcost. Besides, M13 filamentous phages, which have \u223c2700 copies of the 5 kD major pVIII coat protein, can provide great signal amplification when using reporter-conjugated anti-M13 pVIII antibodies."], "score": 0.94091796875}, {"id": "(Petrenko, 2018)", "paper": {"corpus_id": 46974853, "title": "Landscape Phage: Evolution from Phage Display to Nanobiotechnology", "year": 2018, "venue": "Viruses", "authors": [{"name": "V. Petrenko", "authorId": "145050550"}], "n_citations": 42}, "snippets": ["Landscape-phage-based interfaces performed in many ways much more effectively than their natural immunoglobulin counterparts in the same detector platforms. Target-specific landscape-phage probes can be prepared as described in commonly available protocols [58](Brigati et al., 2008)", "Most analytic platforms rely on the use of monoclonal antibodies as biorecognition probes. However, their broad application is limited by high cost, low specificity, less-than-optimal affinity, and sensitivity to environmental stresses. Landscape-phage display is a novel concept that allows for the development of diagnostic and detection interfaces that meet modern criteria for biological detection and monitoring (Petrenko, 2008)21,(Petrenko et al., 2000)(Petrenko et al., 2004)(Petrenko et al., 2003)."], "score": 0.9169921875}, {"id": "(Petrenko et al., 2000)", "paper": {"corpus_id": 9192594, "title": "Phages from landscape libraries as substitute antibodies.", "year": 2000, "venue": "Protein Engineering", "authors": [{"name": "Valery A. Petrenko", "authorId": "2259462628"}, {"name": "George P. Smith", "authorId": "2253030563"}], "n_citations": 136}, "snippets": ["In 'landscape' phage, as in traditional phage-display constructs, foreign peptides or proteins are fused to coat proteins on the surface of a filamentous phage particle. Unlike conventional constructs, however, each virion displays thousands of copies of the peptide in a repeating pattern, subtending a major fraction of the viral surface. The phage body serves as an interacting scaffold to constrain the peptide into a particular conformation, creating a defined organic surface structure ('landscape') that varies from one phage clone to the next. By testing landscape libraries with three representative antigens (streptavidin from the bacterium Streptomyces avidinii, avidin from chicken egg white and beta-galactosidase from Escherichia coli) we have shown that landscape phages may be used as a new type of substitute antibodies-filaments that can bind protein and glycoprotein antigens with nanomolar affinities and high specificity. In many ways these substitute antibodies are more convenient than their natural immunoglobulin counterparts."], "score": 0.0}], "table": null}], "cost": 0.41987699999999994}}
